ID Ca20chr2 standard; DNA; UNK; 2233510 BP.
XX
AC unknown;
XX
DE 2233510 nucleotides
XX
FH Key Location/Qualifiers
FH
FT CDS complement(1358488..1360671)
FT /gene="orf19.1223"
FT /Ca19Contig="Ca19-10103|complement(130..2262)"
FT /synonym="orf19.8809, IPF26112.1, IPF13853.2, Contig4-
FT 1569_0001, orf6.851, CA0205"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1365855..1366712
FT /gene="orf19.1224"
FT /Ca19Contig="Ca19-10103|7446..8303"
FT /synonym="orf19.8810, IPF13846.3, IPF16160.1, Contig4-
FT 2326_0009, orf6.1315, orf6.361, CA0415"
FT /remarks="Upregulated in the presence of human
FT neutrophils; fluconazole-downregulated; repressed by
FT nitric oxide"
FT CDS complement(1367690..1368313)
FT /gene="orf19.1225"
FT /Ca19Contig="Ca19-10103|complement(9281..9904)"
FT /synonym="orf19.8811, IPF26113.1, IPF17492.2, Contig4-
FT 2326_0011, orf6.1316, CA0416"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT possibly spurious ORF (Annotation Working Group
FT prediction)"
FT CDS join(complement(1354514..1354801),
FT complement(1351504..1354512))
FT /gene="orf19.1295"
FT /Ca19Contig="Ca19-10108|complement(676..4035)"
FT /synonym="orf19.8875, IPF26041.1, IPF13980.2, Contig4-
FT 1984_0003, orf6.295, orf6.921, CA0223"
FT /remarks="Putative tRNA-Val synthetase; genes encoding
FT ribosomal subunits, translation factors, and tRNA
FT synthetases are downregulated upon phagocytosis by murine
FT macrophage"
FT CDS join(complement(1356615..1356965),
FT complement(1355249..1356613))
FT /gene="orf19.1296"
FT /Ca19Contig="Ca19-10108|complement(4356..5006)"
FT /synonym="orf19.8876, IPF26039.1, IPF13982.2, orf6.922,
FT CA0224, orf19.82"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1685543..1686106)
FT /gene="orf19.1348"
FT /Ca19Contig="Ca19-10111|905..1468"
FT /synonym="orf19.12588, orf19.8928, IPF25984.1, IPF17661.1,
FT IPF22162.1, IPF9727.2, Contig4-3000_0022, orf6.981,
FT orf6.6328, CA0250, orf19.5122"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1684012..1684452)
FT /gene="orf19.1349"
FT /Ca19Contig="Ca19-10111|2555..2995"
FT /synonym="orf19.8929, IPF25987.1, IPF9726.2, Contig4-
FT 3000_0024, Contig4-3000_0025, orf6.980"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT possibly spurious ORF (Annotation Working Group
FT prediction)"
FT CDS 1682687..1683685
FT /gene="orf19.1350"
FT /Ca19Contig="Ca19-10111|complement(3322..4320)"
FT /synonym="orf19.8930, IPF19616.2, IPF19617.1, Contig4-
FT 3000_0026, orf6.1214, orf6.979, CA0249"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1680114..1680905)
FT /gene="orf19.1351"
FT /Ca19Contig="Ca19-10111|6102..6842"
FT /synonym="orf19.8931, IPF19017.1, IPF19081.2, orf6.1215,
FT orf6.978, CA0366"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1679428..1679982
FT /gene="orf19.1352"
FT /Ca19Contig="Ca19-10111|complement(6974..7528)"
FT /synonym="orf19.8932, IPF25985.1, IPF16416.2, IPF18964.1,
FT Contig4-1837_0001, orf6.1216, orf6.1463, CA0367,
FT orf19.2658"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS join(complement(1677990..1678103),
FT complement(1677562..1677987))
FT /gene="orf19.1353"
FT /Ca19Contig="Ca19-10111|8854..9390"
FT /synonym="orf19.8933, IPF25986.1, IPF11646.2, Contig4-
FT 1837_0006, Contig4-2626_0004, orf6.1217, CA0368"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT transcription downregulated upon yeast-hyphal switch;
FT Ras1p-regulated"
FT CDS complement(1676921..1677526)
FT /gene="orf19.1354"
FT /Ca19Contig="Ca19-10111|9426..10031"
FT /synonym="orf19.8934, orf6.1218, IPF20056, IPF20056.1,
FT IPF20057.1, Contig4-1837_0007, Contig4-2626_0005,
FT orf6.1464, YER67, CA0495, orf19.2659"
FT /remarks="Transcriptionally regulated by iron or by yeast-
FT hyphal switch; expression greater in high iron, decreased
FT upon yeast-hyphal switch; downregulation correlates with
FT clinical development of fluconazole resistance; Ras1p-
FT regulated"
FT CDS complement(2039576..2040619)
FT /gene="orf19.1355"
FT /Ca19Contig="Ca19-10113|174..1217"
FT /synonym="orf19.8935, IPF25953.1, IPF17111.1, Contig4-
FT 1977_0005, orf6.1002, CA0259"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 2038144..2039151
FT /gene="orf19.1356"
FT /Ca19Contig="Ca19-10113|complement(1641..2648)"
FT /synonym="orf19.8936, IPF17674.1, IPF17112.2, Contig4-
FT 1977_0002, Contig4-1977_0003, orf6.1001, orf6.331, CA0258"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS join(2036156..2036434,2036456..2037700)
FT /gene="orf19.1357"
FT /Ca19Contig="Ca19-10113|complement(join(4355..4636,3092..43
FT 36))"
FT /synonym="orf19.8937, IPF17673.3, IPF8921.2, IPF17777.2,
FT IPF17779.2, Contig4-1860_0007, Contig4-1860_0009,
FT orf6.1000, orf6.332, CA6188"
FT /remarks="High affinity, high capacity, hypoxanthine-
FT adenine-guanine-cytosine/ H+ symporter; purine-cytosine
FT permease of pyrimidine salvage; similar to S. cerevisiae
FT Fcy2p"
FT CDS 2032615..2033586
FT /gene="orf19.1358"
FT /Ca19Contig="Ca19-10113|complement(7206..8177)"
FT /synonym="orf19.8938, IPF25958.1, IPF8919.2, Contig4-
FT 1860_0002, orf6.5290, CA3126"
FT /remarks="Transcriptional activator of general amino acid
FT control response; required for Efg1p-dependent
FT pseudohyphal filament induction by amino acid starvation
FT but not by serum; upregulated in the presence of human
FT whole blood or PMN cells"
FT CDS 2029428..2031179
FT /gene="orf19.1359"
FT /Ca19Contig="Ca19-10113|complement(9613..11364)"
FT /synonym="orf19.8939, IPF25938.1, IPF8915.1, Contig4-
FT 2717_0001, orf6.5291, CA3127"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 2028690..2029178
FT /gene="orf19.1360"
FT /Ca19Contig="Ca19-10113|complement(11614..12102)"
FT /synonym="orf19.8940, IPF25969.1, IPF8914.1, Contig4-
FT 2717_0003, orf6.5292, CA3128"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(2028247..2028429)
FT /gene="orf19.1360.1"
FT /Ca19Contig="Ca19-10113|12363..12545"
FT /synonym="IPF25933.1, IPF8912.1, Contig4-2717_0004,
FT CA3129"
FT /remarks="ORF Predicted by Annotation Working Group"
FT CDS complement(2026970..2027626)
FT /gene="orf19.1361"
FT /Ca19Contig="Ca19-10113|13166..13822"
FT /synonym="orf19.8941, IPF25963.1, IPF8911.2, Contig4-
FT 2717_0005, orf6.5293, CA3130"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 2025501..2026802
FT /gene="orf19.1362"
FT /Ca19Contig="Ca19-10113|complement(13990..15291)"
FT /synonym="orf19.8942, IPF25948.1, IPF8910.2, Contig4-
FT 2717_0007, orf6.5294, CA3131"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(2021737..2022915)
FT /gene="orf19.1363"
FT /Ca19Contig="Ca19-10113|17877..19055"
FT /synonym="orf19.8943, IPF25951.1, IPF8904.2, Contig4-
FT 2717_0017, orf6.5295, CA3132"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; Plc1p-
FT regulated; transcriptionally activated by Mnl1p under weak
FT acid stress"
FT CDS 2020125..2021162
FT /gene="orf19.1364"
FT /Ca19Contig="Ca19-10113|complement(19630..20667)"
FT /synonym="orf19.8944, IPF25957.1, IPF16939.2, Contig4-
FT 1729_0001, orf6.5296, CA3133, YBR147w"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT constitutive expression independent of MTL or white-opaque
FT status"
FT CDS complement(2017311..2018831)
FT /gene="orf19.1365"
FT /Ca19Contig="Ca19-10113|21961..23481"
FT /synonym="orf19.8945, IPF25944.1, IPF19972.1, Contig4-
FT 1729_0002, Contig4-2532_0001, orf6.5297, CA3134"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT constitutive expression independent of MTL or white-opaque
FT status"
FT CDS complement(2015641..2016900)
FT /gene="orf19.1366"
FT /Ca19Contig="Ca19-10113|23892..25151"
FT /synonym="orf19.8946, IPF25949.1, IPF8990.1, Contig4-
FT 2532_0003, orf6.5298, CA3135"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 2014585..2015529
FT /gene="orf19.1367"
FT /Ca19Contig="Ca19-10113|complement(25263..26207)"
FT /synonym="orf19.8947, IPF25955.1, IPF8989.1, Contig4-
FT 2532_0004, orf6.5299, CA3136"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 2010703..2012529
FT /gene="orf19.1368"
FT /Ca19Contig="Ca19-10113|complement(28263..30089)"
FT /synonym="orf19.8948, IPF25936.1, IPF8985.3, Contig4-
FT 2532_0008, orf6.291, orf6.5300, CA0045"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(2004485..2005789)
FT /gene="orf19.1369"
FT /Ca19Contig="Ca19-10113|35003..36307"
FT /synonym="orf19.8949, IPF8976.2, IPF19035.2, Contig4-
FT 2176_0002, orf6.1149, orf6.5301, CA3137"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(2002615..2003478)
FT /gene="orf19.1370"
FT /Ca19Contig="Ca19-10113|37314..38177"
FT /synonym="orf19.8950, IPF18486.2, IPF9867.2, Contig4-
FT 1943_0002, orf6.1148, orf6.4156, CA0337"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT expression is regulated upon white-opaque switching;
FT transcription is repressed in response to alpha pheromone
FT in SpiderM medium"
FT CDS 2000795..2002312
FT /gene="orf19.1371"
FT /Ca19Contig="Ca19-10113|complement(38480..39997)"
FT /synonym="orf19.8951, IPF25945.1, IPF9869.2, orf6.1147,
FT orf6.4157, CA0336"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1999553..2000272)
FT /gene="orf19.1372"
FT /Ca19Contig="Ca19-10113|40520..41239"
FT /synonym="orf19.8952, orf6.1146, IPF9870.2, Contig4-
FT 2586_0007, orf6.4158, orf6.530, CA6249"
FT /remarks="Gene transcription regulated by Mig1p and Tup1p"
FT CDS complement(1996318..1999278)
FT /gene="orf19.1373"
FT /Ca19Contig="Ca19-10113|41514..44474"
FT /synonym="orf19.8953, IPF9874.2, IPF9872.3, Contig4-
FT 2586_0004, Contig4-2586_0005, orf6.1145, orf6.4159,
FT CA2308"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1995735..1996307
FT /gene="orf19.1374"
FT /Ca19Contig="Ca19-10113|complement(44485..45057)"
FT /synonym="orf19.8954, IPF25965.1, IPF9875.2, Contig4-
FT 2586_0002, orf6.4160, CA2309"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT possibly spurious ORF (Annotation Working Group
FT prediction)"
FT CDS 1993556..1995271
FT /gene="orf19.1375"
FT /Ca19Contig="Ca19-10113|complement(45521..47242)"
FT /synonym="orf19.8955, IPF25939.1, IPF9877.2, Contig4-
FT 2586_0001, orf6.4161, CA2310"
FT /remarks="Putative alpha-isopropylmalate synthase; fungal-
FT specific (no human or murine homolog); upregulated in the
FT presence of human whole blood or polymorphonuclear (PMN)
FT cells; regulated by Gcn2p and Gcn4p"
FT CDS 1991245..1992132
FT /gene="orf19.1376"
FT /Ca19Contig="Ca19-10113|complement(48660..49547)"
FT /synonym="orf19.8956, IPF25959.1, IPF16993.2, Contig4-
FT 2434_0002, Contig4-2434_0003, orf6.4162, CA2311"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1989269..1990321)
FT /gene="orf19.1377"
FT /Ca19Contig="Ca19-10113|50471..51523"
FT /synonym="orf19.8957, IPF25956.1, IPF16498.2, Contig4-
FT 2434_0006, orf6.4163, CA2312"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT moderately induced at 42 deg"
FT CDS 1987033..1989198
FT /gene="orf19.1378"
FT /Ca19Contig="Ca19-10113|complement(51594..53759)"
FT /synonym="orf19.8958, IPF25930.1, IPF19754.1, Contig4-
FT 2434_0007, orf6.4164, CA2313"
FT /remarks="Translation factor eRF3; shows prion-like
FT aggregation in some, not all, studies; partially
FT complements S. cerevisiae sup35 mutant translation defect;
FT species barrier with S. cerevisiae Sup35p prion; gene not
FT regulated by yeast-hyphal switch"
FT CDS complement(1985043..1986437)
FT /gene="orf19.1381"
FT /Ca19Contig="Ca19-10113|54355..55749"
FT /synonym="orf19.8961, IPF25947.1, IPF14545.2, orf6.4167,
FT CA2314"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1984030..1985010
FT /gene="orf19.1382"
FT /Ca19Contig="Ca19-10113|complement(55782..56762)"
FT /synonym="orf19.8962, IPF14544.2, IPF12389.2, Contig4-
FT 2576_0001, orf6.2082, orf6.4168, CA2315"
FT /remarks="Protein similar to S. cerevisiae Yea4p;
FT transcription is induced in response to alpha pheromone in
FT SpiderM medium"
FT CDS join(complement(1983040..1983651),
FT complement(1981707..1983038))
FT /gene="orf19.1383"
FT /Ca19Contig="Ca19-10113|57141..57782"
FT /synonym="orf19.8963, IPF12388.1, IPF14542.1, IPF12387.1,
FT Contig4-1457_0003, Contig4-1457_0005, Contig4-2576_0002,
FT orf6.2081, orf6.2080, orf6.4169, CA6254, CA2316,
FT orf19.1384"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT transcription is induced in response to alpha pheromone in
FT SpiderM medium"
FT CDS 1981087..1981539
FT /gene="orf19.1386"
FT /Ca19Contig="Ca19-10113|complement(59253..59705)"
FT /synonym="orf19.8964, IPF25970.1, IPF12385.1, Contig4-
FT 2576_0003, orf6.2078, CA0888"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1979787..1980671)
FT /gene="orf19.1387"
FT /Ca19Contig="Ca19-10113|60121..61005"
FT /synonym="orf19.8965, IPF25954.1, IPF12383.2, Contig4-
FT 2576_0004, orf6.2077, CA0887"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1979068..1979724
FT /gene="orf19.1388"
FT /Ca19Contig="Ca19-10113|complement(61068..61724)"
FT /synonym="orf19.8966, IPF25964.1, IPF12382.2, Contig4-
FT 2576_0005, orf6.2076, CA0886"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT induced upon biofilm formation"
FT CDS 1976026..1976517
FT /gene="orf19.1389"
FT /Ca19Contig="Ca19-10113|complement(64275..64766)"
FT /synonym="orf19.8967, IPF18804.2, IPF12381.2, Contig4-
FT 2576_0010, orf6.2075, orf6.2241, CA0885"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1973815..1975140
FT /gene="orf19.1390"
FT /Ca19Contig="Ca19-10113|complement(65652..66977)"
FT /synonym="orf19.8968, IPF19894.1, IPF11071.3, Contig4-
FT 2636_0003, Contig4-2636_0004, MPI, orf6.2074, orf6.2242,
FT CA0988"
FT /remarks="Phosphomannose isomerase; cell wall biosynthesis
FT enzyme; drug target; functional homolog of S. cerevisiae
FT and E. coli phosphomannose isomerase; Gcn4p-regulated;
FT repressed by 3-AT; induced on adherence to polystyrene,
FT phagocytosis"
FT CDS complement(1972572..1973081)
FT /gene="orf19.1391"
FT /Ca19Contig="Ca19-10113|67711..68220"
FT /synonym="orf19.8969, IPF25966.1, IPF11069.2, Contig4-
FT 2636_0007, orf6.2243, CA0989"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1970372..1972585
FT /gene="orf19.1392"
FT /Ca19Contig="Ca19-10113|complement(68207..70420)"
FT /synonym="orf19.8970, IPF25932.1, IPF11068.1, Contig4-
FT 2636_0008, orf6.2244, CA0990"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1968927..1970027
FT /gene="orf19.1393"
FT /Ca19Contig="Ca19-10113|complement(70765..71865)"
FT /synonym="orf19.8971, IPF11065.2, IPF18374.2, Contig4-
FT 2636_0009, orf6.2245, orf6.5346, CA0991"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1967348..1967848)
FT /gene="orf19.1394"
FT /Ca19Contig="Ca19-10113|72944..73444"
FT /synonym="orf19.8972, IPF11063.2, IPF29472.1, orf6.2246,
FT orf6.5347, YCR090, CA0992"
FT /remarks="Protein not essential for viability"
FT CDS complement(1963474..1964490)
FT /gene="orf19.1395"
FT /Ca19Contig="Ca19-10113|76302..77318"
FT /synonym="orf19.8973, IPF11059.2, IPF7686.2, Contig4-
FT 2842_0004, orf6.5348, CA3169"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1962097..1963260
FT /gene="orf19.1396"
FT /Ca19Contig="Ca19-10113|complement(77532..78695)"
FT /synonym="orf19.8974, IPF25950.1, IPF7685.2, Contig4-
FT 2842_0005, orf6.5349, CA3170"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1959247..1959957)
FT /gene="orf19.1397"
FT /Ca19Contig="Ca19-10113|80835..81545"
FT /synonym="orf19.8975, IPF25962.1, IPF7681.2, Contig4-
FT 2842_0012, orf6.5350, CA3171"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1956208..1958451)
FT /gene="orf19.1400"
FT /Ca19Contig="Ca19-10113|82341..84584"
FT /synonym="orf19.8978, IPF25931.1, IPF7679.2, Contig4-
FT 2842_0014, orf6.5353, CA3172"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1952624..1954585
FT /gene="orf19.1401"
FT /Ca19Contig="Ca19-10113|complement(86207..88168)"
FT /synonym="orf6.5354, IPF7676.3, IPF14145.2, Contig4-
FT 2651_0004, CA3173"
FT /remarks="Cell wall adhesin required for cell-cell
FT adhesion and biofilm formation; GPI anchored; Efg1p-
FT regulated; suppresses polystyrene or cell adhesion,
FT filamentation, invasive growth defects of S. cerevisiae
FT flo8 or flo11 mutant"
FT CDS complement(1947593..1949173)
FT /gene="orf19.1402"
FT /Ca19Contig="Ca19-10113|91619..93199"
FT /synonym="orf19.8980, IPF25943.1, IPF11584.2, Contig4-
FT 2651_0001, orf6.5355, CA3174"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1944988..1946706)
FT /gene="orf19.1403"
FT /Ca19Contig="Ca19-10113|94086..95804"
FT /synonym="orf19.8981, IPF25937.1, IPF11587.2, Contig4-
FT 2113_0002, orf6.5356, CA3175"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1943421..1944824
FT /gene="orf19.1404"
FT /Ca19Contig="Ca19-10113|complement(95968..97371)"
FT /synonym="orf19.8982, IPF25946.1, IPF11588.2, Contig4-
FT 2113_0003, orf6.5357, CA3176"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1942264..1943229
FT /gene="orf19.1405"
FT /Ca19Contig="Ca19-10113|complement(97563..98528)"
FT /synonym="orf19.8983, IPF25952.1, IPF11589.2, Contig4-
FT 2113_0004, orf6.5358, CA3177"
FT /remarks="Transcription is regulated upon yeast-hyphal
FT switch"
FT CDS 1940928..1941698
FT /gene="orf19.1406"
FT /Ca19Contig="Ca19-10113|complement(99043..99813)"
FT /synonym="orf19.8984, IPF25961.1, IPF19974.1, Contig4-
FT 2113_0005, Contig4-2113_0006, orf6.5359, CA3178"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1696539..1697732
FT /gene="orf19.1433"
FT /Ca19Contig="Ca19-10117|complement(335..1528)"
FT /synonym="orf19.9007, IPF25891.1, IPF19066.1, orf6.1039,
FT CA0273"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; shows
FT colony morphology-related gene regulation by Ssn6p"
FT CDS complement(1693414..1695561)
FT /gene="orf19.1434"
FT /Ca19Contig="Ca19-10117|2505..4652"
FT /synonym="orf19.9008, IPF9733.2, IPF17695.2, Contig4-
FT 2267_0004, orf6.1038, orf6.1203, CA0272"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1691580..1692956)
FT /gene="orf19.1435"
FT /Ca19Contig="Ca19-10117|5059..6435"
FT /synonym="orf19.12585, orf19.9009, TEF-1, IPF9732.2,
FT IPF29461.1, IPF22137.1, IPF28153.1, Contig4-2267_0001,
FT orf6.1202, orf6.6331, CA0362, orf19.5119, TEF2-2"
FT /remarks="Translation elongation factor 1-alpha, detected
FT at surface of yeast-form and hyphal cells; binds human
FT plasminogen; macrophage/pseudohyphal-induced; upregulated
FT in an RHE model of oral candidiasis and in clinical oral
FT candidiasis isolates"
FT CDS complement(971832..974900)
FT /gene="orf19.144"
FT /Ca19Contig="Ca19-10037|complement(3003..6071)"
FT /synonym="orf19.7784, IPF16740.2, IPF29942.1, Contig4-
FT 2900_0027, orf6.1176, CA0350"
FT /remarks="Protein likely to be essential for growth, based
FT on an insertional mutagenesis strategy; similar to S.
FT cerevisiae Snu114p, which is an RNA helicase involved in
FT pre-mRNA splicing"
FT CDS join(complement(238449..239222),
FT complement(237311..238450))
FT /gene="orf19.1441"
FT /Ca19Contig="Ca19-10119|complement(275..2131)"
FT /synonym="orf19.9016, IPF25761.1, IPF14657.2, Contig4-
FT 2134_0003, orf6.1060, CA0284"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS join(241262..242443,242451..243371)
FT /gene="orf19.1442"
FT /Ca19Contig="Ca19-10119|join(4171..5352,5360..6280)"
FT /synonym="orf19.9017, orf19.9018, IPF15731.2, IPF15733.2,
FT IPF14660.3, IPF29416.1, PLB4.3, Contig4-2174_0003, Contig4-
FT 2174_0004, orf6.1059, orf6.795, orf6.796, PLB4.5f,
FT PLB4.3f, CA0185, CA0186, orf19.1443"
FT /remarks="Putative phospholipase B; Hog1p-induced;
FT regulated by Ssn6p; putative GPI-anchor; repressed during
FT cell wall regeneration"
FT CDS 244143..245711
FT /gene="orf19.1444"
FT /Ca19Contig="Ca19-10119|7052..8620"
FT /synonym="orf19.9019, IPF17555.3, IPF29409.1, Contig4-
FT 2174_0001, orf6.7129, CA4555"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(245940..248651)
FT /gene="orf19.1445"
FT /Ca19Contig="Ca19-10119|complement(8849..11560)"
FT /synonym="orf19.9020, IPF25740.1, IPF7874.2, Contig4-
FT 3018_0027, Contig4-3018_0028, orf6.7128, CA4554"
FT /remarks="Protein similar to S. cerevisiae Esc4p, which
FT represses transposition; transposon mutation affects
FT filamentous growth"
FT CDS complement(249150..250628)
FT /gene="orf19.1446"
FT /Ca19Contig="Ca19-10119|complement(12059..13537)"
FT /synonym="orf19.9021, IPF25776.1, IPF7873.2, Contig4-
FT 3018_0026, orf6.7127, CA4553"
FT /remarks="B-type mitotic cyclin (cyclin-dependent protein
FT kinase regulatory subunit); essential; required for wild-
FT type mitotic exit; role in cell polarization; interacts
FT with catalytic subunit Cdk1p"
FT CDS complement(254700..256316)
FT /gene="orf19.1447"
FT /Ca19Contig="Ca19-10119|complement(17609..19225)"
FT /synonym="orf19.9022, IPF25767.1, IPF7869.1, Contig4-
FT 3018_0021, orf6.7126, CA4552"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 256853..257419
FT /gene="orf19.1448"
FT /Ca19Contig="Ca19-10119|19762..20328"
FT /synonym="orf19.9023, IPF25817.1, IPF7867.1, Contig4-
FT 3018_0020, orf6.7125, CA4551"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT flucytosine induced; repressed by nitric oxide"
FT CDS join(complement(257944..257965),
FT complement(257561..257814))
FT /gene="orf19.1448.1"
FT /remarks="Predicted ORF in Assembly 20 and 21; gene has
FT intron"
FT CDS complement(258198..258887)
FT /gene="orf19.1449"
FT /Ca19Contig="Ca19-10119|complement(21107..21796)"
FT /synonym="orf19.9024, IPF25807.1, IPF7863.1, IPF7863,
FT Contig4-3018_0017, orf6.7124, CA4549"
FT /remarks="Increased transcription is observed in an azole-
FT resistant strain that overexpresses MDR1"
FT CDS join(complement(975751..976207),
FT complement(975394..975749))
FT /gene="orf19.145"
FT /Ca19Contig="Ca19-10037|complement(join(6923..7378,6565..69
FT 21))"
FT /synonym="orf19.7785, orf19.7786, IPF27151.1, IPF27153.1,
FT IPF19620.1, IPF19621.1, orf6.1177, orf6.1178, CA0351,
FT CA0352, orf19.146"
FT /remarks="Protein similar to S. cerevisiae Rpb4p, which is
FT a component of RNA polymerase II; transposon mutation
FT affects filamentous growth"
FT CDS complement(259169..260275)
FT /gene="orf19.1450"
FT /Ca19Contig="Ca19-10119|complement(22078..23184)"
FT /synonym="orf19.9025, IPF25791.1, IPF7862.1, Contig4-
FT 3018_0016, orf6.7123, CA4548"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT possibly spurious ORF (Annotation Working Group
FT prediction)"
FT CDS 260904..265901
FT /gene="orf19.1451"
FT /Ca19Contig="Ca19-10119|23813..28810"
FT /synonym="orf19.9026, IPF25829.1, IPF6242.2, Contig4-
FT 3018_0009, Contig4-3018_0011, Contig4-3018_0012, Contig4-
FT 3018_0014, orf6.7122, CA4547, orf6.514"
FT /remarks="Protein with similarity to S. cerevisiae Srb9p
FT transcription mediator; transposon mutation affects
FT filamentous growth; suppresses S. cerevisiae diploid
FT filamentous (flo8, ste7, ste12, tec1) or haploid invasive
FT (flo8) mutant growth defects"
FT CDS 266073..268943
FT /gene="orf19.1453"
FT /Ca19Contig="Ca19-10119|28982..31852"
FT /synonym="orf19.9028, IPF25736.1, IPF6247.1, Contig4-
FT 3018_0007, orf6.7120, CA4546"
FT /remarks="Protein similar to S. cerevisiae Spt5p
FT transcription elongation factor; transposon mutation
FT affects filamentous growth"
FT CDS 270381..270815
FT /gene="orf19.1456"
FT /Ca19Contig="Ca19-10119|33290..33724"
FT /synonym="IPF25833.1, IPF29424.1, orf6.7117"
FT /remarks="ORF Predicted by Annotation Working Group;
FT possibly spurious ORF (Annotation Working Group
FT prediction)"
FT CDS complement(269105..270523)
FT /gene="orf19.1457"
FT /Ca19Contig="Ca19-10119|complement(32014..33537)"
FT /synonym="orf19.9032, IPF25773.1, IPF6250.1, Contig4-
FT 3018_0004, orf6.7116, CA4545"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(270817..271629)
FT /gene="orf19.1458"
FT /Ca19Contig="Ca19-10119|complement(33726..34571)"
FT /synonym="orf19.9033, IPF25800.1, IPF6252.1, Contig4-
FT 3018_0001, orf6.7115, CA4544"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 271870..272952
FT /gene="orf19.1459"
FT /Ca19Contig="Ca19-10119|34779..35861"
FT /synonym="orf19.9034, IPF25793.1, IPF6254.1, orf6.7114,
FT CA4543"
FT /remarks="Protein similar to S. cerevisiae Ppe1p; shows
FT genetic interaction with some genes involved in diploid
FT filamentous growth and haploid invasive growth in S.
FT cerevisiae"
FT CDS complement(272977..275121)
FT /gene="orf19.1460"
FT /Ca19Contig="Ca19-10119|complement(35886..38030)"
FT /synonym="orf19.9035, IPF25753.1, IPF6255.1, Contig4-
FT 2555_0007, orf6.7113, CA4542"
FT /remarks="Putative glutamine-dependent NAD synthetase,
FT involved in NAD salvage pathway"
FT CDS 275686..276855
FT /gene="orf19.1461"
FT /Ca19Contig="Ca19-10119|38523..39764"
FT /synonym="orf19.9036, IPF25785.1, IPF6257.1, Contig4-
FT 2555_0005, orf6.7112, CA4541"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT possibly transcriptionally regulated upon hyphal
FT formation"
FT CDS 277247..279592
FT /gene="orf19.1462"
FT /Ca19Contig="Ca19-10119|40156..42501"
FT /synonym="orf19.9037, IPF25747.1, IPF6259.2, Contig4-
FT 2555_0003, orf6.7111, CA4540"
FT /remarks="Transcription is regulated by Nrg1p"
FT CDS 280371..282209
FT /gene="orf19.1464"
FT /Ca19Contig="Ca19-10119|43280..45118"
FT /synonym="orf19.9039, IPF18203.2, IPF6260.2, orf6.7109,
FT CA4539"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 282434..282979
FT /gene="orf19.1465"
FT /Ca19Contig="Ca19-10119|45343..45888"
FT /synonym="orf19.9040, IPF25815.1, IPF20018.1, Contig4-
FT 3015_0023, Contig4-3015_0024, orf6.7108, CA4538"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 283281..283994
FT /gene="orf19.1466"
FT /Ca19Contig="Ca19-10119|46136..46903"
FT /synonym="orf19.9041, IPF25805.1, IPF4375.1, Contig4-
FT 3015_0021, orf6.7107, CA4537"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 284349..284753
FT /gene="orf19.1467"
FT /Ca19Contig="Ca19-10119|47258..47662"
FT /synonym="orf19.9042, IPF25830.1, IPF4376.1, Contig4-
FT 3015_0020, orf6.7106, CA4536"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT flucytosine induced; repressed by nitric oxide"
FT CDS complement(285160..286719)
FT /gene="orf19.1468"
FT /Ca19Contig="Ca19-10119|complement(48069..49628)"
FT /synonym="orf19.9043, IPF25772.1, IPF4377.1, Contig4-
FT 3015_0018, orf6.7105, CA4535"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS join(complement(978361..979366),
FT complement(976935..978361))
FT /gene="orf19.147"
FT /Ca19Contig="Ca19-10037|complement(join(9533..10537,8106..9
FT 533))"
FT /synonym="orf19.7787, orf19.7788, IPF27150.1, IPF16042.2,
FT IPF16043.2, IPF19456.2, orf6.1179, orf6.63, orf6.1180,
FT CA0353, CA0354, orf19.148"
FT /remarks="Predicted serine-threonine protein kinase
FT involved in hyphal growth regulation and biofilm
FT formation; induced in core caspofungin response"
FT CDS complement(287989..288348)
FT /gene="orf19.1470"
FT /Ca19Contig="Ca19-10119|complement(50898..51257)"
FT /synonym="orf19.9045, IPF25866.1, IPF4380.2, Contig4-
FT 3015_0015, orf6.7103, CA4534"
FT /remarks="Predicted ribosomal protein; regulated by Nrg1p,
FT Tup1p; genes encoding cytoplasmic ribosomal subunits,
FT translation factors, and tRNA synthetases are
FT downregulated upon phagocytosis by murine macrophage;
FT intron in 5'-UTR"
FT CDS 290025..290498
FT /gene="orf19.1471"
FT /Ca19Contig="Ca19-10119|52934..53407"
FT /synonym="orf19.9046, IPF25835.1, IPF20017.1, Contig4-
FT 3015_0013, orf6.7102, CA4533"
FT /remarks="Protein described as subunit IV of cytochrome c
FT oxidase; transcription is regulated by Mig1p;
FT macrophage/pseudohyphal-induced gene; macrophage-induced
FT protein; repressed by nitric oxide: intron in 5'-UTR"
FT CDS 291252..292346
FT /gene="orf19.1473"
FT /Ca19Contig="Ca19-10119|54161..55255"
FT /synonym="orf19.9048, IPF25790.1, IPF4386.1, Contig4-
FT 3015_0011, orf6.7100, CA4532"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT transcription is induced in response to alpha pheromone in
FT SpiderM medium"
FT CDS 292600..296373
FT /gene="orf19.1474"
FT /Ca19Contig="Ca19-10119|55509..59282"
FT /synonym="orf19.9049, IPF25863.1, IPF4392.1, Contig4-
FT 3015_0009, orf6.7099, CA4531"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT transcription is regulated by Nrg1p and Mig1p; fungal-
FT specific (no human or murine homolog)"
FT CDS 296693..298324
FT /gene="orf19.1476"
FT /Ca19Contig="Ca19-10119|59602..61233"
FT /synonym="orf19.9051, IPF25770.1, IPF4394.1, Contig4-
FT 3015_0008, orf6.7097, CA4530"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(298327..298905)
FT /gene="orf19.1477"
FT /Ca19Contig="Ca19-10119|complement(61236..61814)"
FT /synonym="orf19.9052, IPF25812.1, IPF4395.1, Contig4-
FT 3015_0007, orf6.7096, CA4529"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(299374..301629)
FT /gene="orf19.1478"
FT /Ca19Contig="Ca19-10119|complement(62283..64538)"
FT /synonym="orf19.9053, IPF25749.1, IPF4396.1, Contig4-
FT 3015_0004, Contig4-3015_0005, orf6.7095, CA4528"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(302000..304342)
FT /gene="orf19.1479"
FT /Ca19Contig="Ca19-10119|complement(64909..67251)"
FT /synonym="orf19.9054, IPF4398.3, IPF29400.1, Contig4-
FT 3015_0002, orf6.2103, orf6.7094, CA4527"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 305612..306142
FT /gene="orf19.1480"
FT /Ca19Contig="Ca19-10119|68521..69051"
FT /synonym="orf19.9055, IPF25808.1, IPF4401.2, Contig4-
FT 2219_0007, orf6.2104, CA0903"
FT /remarks="Protein described as succinate dehydrogenase,
FT enzyme of citric acid cycle; downregulated by Efg1p;
FT repressed by nitric oxide"
FT CDS complement(306528..309044)
FT /gene="orf19.1481"
FT /Ca19Contig="Ca19-10119|complement(69437..71953)"
FT /synonym="orf19.9056, IPF25743.1, IPF4403.2, Contig4-
FT 2219_0003, Contig4-2219_0005, orf6.2105, CA0904"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 309880..310200
FT /gene="orf19.1482"
FT /Ca19Contig="Ca19-10119|72789..73109"
FT /synonym="orf19.9057, IPF25838.1, IPF4405.1, Contig4-
FT 2219_0002, orf6.2106, CA0905"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT expression regulated during planktonic growth"
FT CDS complement(310339..310734)
FT /gene="orf19.1483"
FT /Ca19Contig="Ca19-10119|complement(73248..73643)"
FT /synonym="orf19.9058, IPF25853.1, IPF4406.2, Contig4-
FT 2219_0001, orf6.2107, CA0906"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 311006..311764
FT /gene="orf19.1484"
FT /Ca19Contig="Ca19-10119|73915..74673"
FT /synonym="orf19.9059, IPF25804.1, IPF19889.1, Contig4-
FT 2638_0001, orf6.2108, CA0907"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(311945..312286)
FT /gene="orf19.1485"
FT /Ca19Contig="Ca19-10119|complement(74854..75195)"
FT /synonym="orf19.9060, IPF6016.2, Contig4-2638_0003,
FT orf6.2109, CA0908"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(314796..315293)
FT /gene="orf19.1486"
FT /Ca19Contig="Ca19-10119|complement(77705..78202)"
FT /synonym="orf19.9061, IPF6011.2, IPF6010.3, Contig4-
FT 2638_0008, orf6.2256, CA1000"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT possibly spurious ORF (Annotation Working Group
FT prediction)"
FT CDS complement(322729..323388)
FT /gene="orf19.1488"
FT /Ca19Contig="Ca19-10119|complement(85638..86297)"
FT /synonym="orf19.9065, IPF6006.2, IPF29419.1, Contig4-
FT 2801_0001, orf6.2260, CA1001"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT possibly spurious ORF (Annotation Working Group
FT prediction)"
FT CDS 980040..980477
FT /gene="orf19.149"
FT /Ca19Contig="Ca19-10037|11211..11648"
FT /synonym="IPF27154.1, IPF29941.1, orf6.62"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 327819..332048
FT /gene="orf19.1490"
FT /Ca19Contig="Ca19-10119|90728..94957"
FT /synonym="orf19.9067, IPF25849.1, IPF6003.1, Contig4-
FT 2801_0007, orf6.2804, CA1345"
FT /remarks="Protein of unknown function; transcription is
FT negatively regulated by Rim101p"
FT CDS complement(334296..336140)
FT /gene="orf19.1491"
FT /Ca19Contig="Ca19-10119|complement(97205..99049)"
FT /synonym="orf19.9068, IPF14405.2, IPF5991.3, Contig4-
FT 2801_0010, orf6.1460, orf6.2805, CA0492"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 336694..338661
FT /gene="orf19.1492"
FT /Ca19Contig="Ca19-10119|99603..101570"
FT /synonym="orf19.9069, IPF25748.1, IPF14401.2, Contig4-
FT 2358_0005, orf6.1461, CA0493"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(338719..340677)
FT /gene="orf19.1493"
FT /Ca19Contig="Ca19-10119|complement(101628..103586)"
FT /synonym="orf19.9070, IPF14400.2, IPF16848.2, Contig4-
FT 2358_0001, orf6.1462, orf6.936, CA0494"
FT /remarks="Protein similar to S. cerevisiae Rad7p, which is
FT a subunit of the Nucleotide Excision Repair Factor 4;
FT induced under hydroxyurea treatment"
FT CDS join(341360..341425,341611..342798)
FT /gene="orf19.1494"
FT /Ca19Contig="Ca19-10119|104661..105707"
FT /synonym="orf19.9071, IPF25788.1, IPF16846.2, Contig4-
FT 2358_0003, orf6.935, CA0231"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(342954..343751)
FT /gene="orf19.1495"
FT /Ca19Contig="Ca19-10119|complement(105863..106660)"
FT /synonym="orf19.9072, IPF16638.1, IPF19099.1, Contig4-
FT 2358_0004, orf6.3546, orf6.934, CA1860"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(344114..345469)
FT /gene="orf19.1496"
FT /Ca19Contig="Ca19-10119|complement(107023..108378)"
FT /synonym="orf19.9073, IPF19614.1, IPF19615.1, orf6.933,
FT orf6.3545, CA1859"
FT /remarks="Putative transcription factor with zinc finger
FT DNA-binding motif; possibly spurious ORF (Annotation
FT Working Group prediction)"
FT CDS complement(345614..346726)
FT /gene="orf19.1497"
FT /Ca19Contig="Ca19-10119|complement(108523..109635)"
FT /synonym="IPF19100.2, CA6255"
FT /remarks="Putative transcription factor with zinc cluster
FT DNA-binding motif"
FT CDS 350851..354285
FT /gene="orf19.1499"
FT /Ca19Contig="Ca19-10119|113760..117194"
FT /synonym="orf19.9075, IPF25868.1, IPF15240.2, Contig4-
FT 2582_0009, orf6.3543, CA6190"
FT /remarks="Predicted zinc-finger protein of unknown
FT function; has similarity to S. cerevisiae transcription
FT factors"
FT CDS 981212..981676
FT /gene="orf19.150"
FT /Ca19Contig="Ca19-10037|12383..12847"
FT /synonym="orf19.7790, IPF16036.1, IPF29940.1, Contig4-
FT 1742_0002, orf6.75, CA0010"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(354412..355935)
FT /gene="orf19.1500"
FT /Ca19Contig="Ca19-10119|complement(117321..118844)"
FT /synonym="orf19.9076, IPF15344.2, IPF15343.3, Contig4-
FT 2650_0016, orf6.3542, CA1858"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 356251..357018
FT /gene="orf19.1502"
FT /Ca19Contig="Ca19-10119|119160..119927"
FT /synonym="orf19.9078, IPF25801.1, IPF15345.3, Contig4-
FT 2650_0014, orf6.192, orf6.3540, CA0028"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(357531..360092)
FT /gene="orf19.1504"
FT /Ca19Contig="Ca19-10119|complement(120440..123001)"
FT /synonym="orf19.9080, IPF15348.2, IPF29398.1, Contig4-
FT 2650_0011, orf6.193, orf6.3538, CA1857"
FT /remarks="Putative patatin-like phospholipase; fungal-
FT specific (no human or murine homolog)"
FT CDS complement(361020..362057)
FT /gene="orf19.1505"
FT /Ca19Contig="Ca19-10119|complement(123929..124966)"
FT /synonym="orf19.9081, IPF13689, IPF13689.2, IPF18995.2,
FT Contig4-2650_0009, orf6.1309, orf6.3537, CA1856"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(364318..364743)
FT /gene="orf19.1506"
FT /Ca19Contig="Ca19-10119|complement(127227..127652)"
FT /synonym="orf19.9082, IPF25845.1, IPF29430.1, Contig4-
FT 2650_0003, orf6.1308"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT possibly spurious ORF (Annotation Working Group
FT prediction)"
FT CDS complement(365202..367178)
FT /gene="orf19.1507"
FT /Ca19Contig="Ca19-10119|complement(128111..130087)"
FT /synonym="orf19.9083, IPF25758.1, IPF17676.2, Contig4-
FT 1513_0004, Contig4-2650_0001, Contig4-2650_0018,
FT orf6.1307, CA0411"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; Plc1p-
FT regulated"
FT CDS complement(367370..367705)
FT /gene="orf19.1508"
FT /Ca19Contig="Ca19-10119|complement(130279..130614)"
FT /synonym="IPF29448.1, orf6.1306"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(370008..372779)
FT /gene="orf19.1509"
FT /Ca19Contig="Ca19-10119|complement(132917..135688)"
FT /synonym="orf19.9084, IPF19576.1, IPF19577.1, Contig4-
FT 1782_0002, orf6.344, orf6.3960, CA2177"
FT /remarks="Protein not essential for viability; similar to
FT S. cerevisiae Rod1p, which is a membrane protein with a
FT role in drug tolerance; repressed by Rgt1p"
FT CDS join(complement(983858..984493),
FT complement(982480..983856))
FT /gene="orf19.151"
FT /Ca19Contig="Ca19-10037|complement(13651..15048)"
FT /synonym="orf19.7792, IPF19097.2, IPF17861.2, IPF19195.1,
FT orf6.662, orf6.76, orf6.660, CA0144, CA0143, orf19.153"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT hyphal induced; macrophage induced"
FT CDS complement(374699..376579)
FT /gene="orf19.1510"
FT /Ca19Contig="Ca19-10119|complement(137608..139488)"
FT /synonym="orf19.9085, IPF9282, IPF25762.1, IPF9282.2,
FT Contig4-1782_0005, orf6.3961, CA2178"
FT /remarks="Protein not essential for viability"
FT CDS complement(378086..385960)
FT /gene="orf19.1513"
FT /Ca19Contig="Ca19-10119|complement(140995..148869)"
FT /synonym="orf19.9088, IPF9288.2, IPF29418.1, Contig4-
FT 2754_0006, Contig4-2754_0007, Contig4-2754_0009,
FT orf6.3964, CA2179"
FT /remarks="Phosphatidylinositol 3-phosphate 5-kinase;
FT required for hyphal growth on solid media, and for wild-
FT type vacuolar morphology and acidification; not required
FT for wild-type virulence in mouse systemic infection or for
FT adherence to HeLa cells"
FT CDS 387020..388042
FT /gene="orf19.1514"
FT /Ca19Contig="Ca19-10119|149929..150951"
FT /synonym="orf19.9089, IPF9290.2, IPF8244.2, Contig4-
FT 1806_0003, Contig4-2754_0001, orf6.3399, orf6.3965,
FT CA2180"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(388256..389422)
FT /gene="orf19.1515"
FT /Ca19Contig="Ca19-10119|complement(151165..152331)"
FT /synonym="orf19.9090, IPF25787.1, IPF8245.2, Contig4-
FT 1806_0001, orf6.3398, orf6.3966, CA1753"
FT /remarks="Chitinase; similar to S. cerevisiae sporulation-
FT specific Cts2p; functionally complements A. gossypii cts2
FT mutant sporulation defect; homozygous null mutation causes
FT no obvious defects; transcription decreases upon yeast-to-
FT hyphal switch"
FT CDS 389772..392156
FT /gene="orf19.1516"
FT /Ca19Contig="Ca19-10119|152681..155065"
FT /synonym="orf19.9091, IPF17697.2, IPF8246.2, Contig4-
FT 2807_0008, orf6.3397, orf6.3967, CA1752"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS join(392787..392841,392955..394015)
FT /gene="orf19.1517"
FT /Ca19Contig="Ca19-10119|156106..156924"
FT /synonym="orf19.9092, orf6.3396, IPF25795.1, IPF8248.2,
FT Contig4-2807_0007, CA1751"
FT /remarks="3-Deoxy-D-arabinoheptulosonate-7-phosphate
FT synthase; enzyme of aromatic amino acid biosynthesis; GCN-
FT regulated; feedback-inhibited by phenylalanine when
FT heterologously produced in S. cerevisiae; Aro3p and Aro4p
FT catalyze the same reaction"
FT CDS 394460..397762
FT /gene="orf19.1519"
FT /Ca19Contig="Ca19-10119|157369..160671"
FT /synonym="orf19.9094, IPF25872.1, IPF8252.2, Contig4-
FT 2807_0006, orf6.3394, CA1750"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(398233..401361)
FT /gene="orf19.1522"
FT /Ca19Contig="Ca19-10119|complement(161142..164270)"
FT /synonym="orf19.9097, IPF25875.1, IPF8257.2, Contig4-
FT 2807_0004, orf6.1171, orf6.3391, CA1748"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(402586..404244)
FT /gene="orf19.1523"
FT /Ca19Contig="Ca19-10119|complement(165495..167153)"
FT /synonym="orf19.9098, IPF15750.2, IPF15749.3, Contig4-
FT 2017_0003, orf6.1172, orf6.3390, CA0348"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 405698..407173
FT /gene="orf19.1524"
FT /Ca19Contig="Ca19-10119|168607..170082"
FT /synonym="orf19.9100, IPF15746.3, IPF16732.2, Contig4-
FT 1766_0002, Contig4-2017_0004, orf6.1173, orf6.1204,
FT CA0363"
FT /remarks="Septin; mutant has no obvious phenotype"
FT CDS 408330..409526
FT /gene="orf19.1525"
FT /Ca19Contig="Ca19-10119|171239..172435"
FT /synonym="orf19.9101, IPF18883.2, IPF15983.2, Contig4-
FT 2444_0002, orf6.1205, orf6.1860, CA0364"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 410394..415466
FT /gene="orf19.1526"
FT /Ca19Contig="Ca19-10119|173303..178375"
FT /synonym="orf19.9102, IPF15319.2, IPF15980.3, Contig4-
FT 2444_0006, Contig4-2444_0007, orf6.1206, orf6.1859,
FT CA0747"
FT /remarks="Protein involved in transcriptional regulation;
FT ortholog of S. cerevisiae Snf2p, which is the catalytic
FT subunit of the SWI/SNF chromatin remodeling complex;
FT interacts with Swi1p; SWI/SNF complex is essential for
FT hyphal growth and virulence"
FT CDS complement(415635..416189)
FT /gene="orf19.1527"
FT /Ca19Contig="Ca19-10119|complement(178544..179098)"
FT /synonym="orf19.9103, IPF25813.1, IPF14921.2, Contig4-
FT 2467_0002, orf6.1858, CA0746"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT possibly spurious ORF (Annotation Working Group
FT prediction)"
FT CDS 416691..417746
FT /gene="orf19.1528"
FT /Ca19Contig="Ca19-10119|179600..180655"
FT /synonym="orf19.9104, IPF14920.2, IPF29413.1, Contig4-
FT 2467_0004, Contig4-2467_0005, orf6.1857, CA0745"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(417986..419014)
FT /gene="orf19.1529"
FT /Ca19Contig="Ca19-10119|complement(180895..181923)"
FT /synonym="orf19.9105, IPF14919.2, IPF29414.1, Contig4-
FT 2467_0007, orf6.1856, CA0744"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT macrophage-induced gene; possibly spurious ORF (Annotation
FT Working Group prediction)"
FT CDS complement(419107..419628)
FT /gene="orf19.1530"
FT /Ca19Contig="Ca19-10119|complement(182016..182537)"
FT /synonym="IPF29422.1, CA6256"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(419868..422243)
FT /gene="orf19.1531"
FT /Ca19Contig="Ca19-10119|complement(182777..185152)"
FT /synonym="orf19.9106, IPF25746.1, IPF16839.3, Contig4-
FT 2467_0008, orf6.1855, orf6.931, CA0743"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 423047..424117
FT /gene="orf19.1532"
FT /Ca19Contig="Ca19-10119|185956..187026"
FT /synonym="orf19.9107, IPF25786.1, IPF17420.2, Contig4-
FT 2467_0011, orf6.932, CA0230"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 425191..426567
FT /gene="orf19.1533"
FT /Ca19Contig="Ca19-10119|188100..189476"
FT /synonym="orf19.9108, IPF15116.1, IPF17419.2, Contig4-
FT 1607_0002, orf6.839, CA0201"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 427524..429299
FT /gene="orf19.1534"
FT /Ca19Contig="Ca19-10119|190433..192208"
FT /synonym="orf19.9109, orf6.1064, IPF15119.2, IPF19059.2,
FT orf6.838, CA0200"
FT /remarks="Protein similar to S. cerevisiae Zrt3p, which is
FT a transporter of zinc ions; predicted Kex2p substrate"
FT CDS complement(429770..430564)
FT /gene="orf19.1535"
FT /Ca19Contig="Ca19-10119|complement(192679..193473)"
FT /synonym="orf19.9110, IPF25803.1, IPF14392.2, Contig4-
FT 2088_0007, orf6.1063, CA0285"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT possibly spurious ORF (Annotation Working Group
FT prediction)"
FT CDS join(433315..433711,433715..434751)
FT /gene="orf19.1536"
FT /Ca19Contig="Ca19-10119|join(196224..196619,196623..197660)
FT "
FT /synonym="orf19.9111, IPF19060.1, Contig4-2088_0003,
FT orf6.1061, orf6.1062, orf6.2308, CA6257, CA1030,
FT orf19.1537"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(434961..436229)
FT /gene="orf19.1538"
FT /Ca19Contig="Ca19-10119|complement(197870..199138)"
FT /synonym="orf19.9112, IPF14397.2, IPF29411.1, Contig4-
FT 2088_0010, orf6.2307, CA1029"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT macrophage/pseudohyphal-repressed"
FT CDS complement(437747..438946)
FT /gene="orf19.1539"
FT /Ca19Contig="Ca19-10119|complement(200656..201855)"
FT /synonym="orf19.9113, IPF25782.1, IPF6488.2, Contig4-
FT 2381_0006, orf6.2306, CA1028"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT highly induced upon biofilm formation"
FT CDS complement(985034..986119)
FT /gene="orf19.154"
FT /Ca19Contig="Ca19-10037|complement(16205..17290)"
FT /synonym="orf19.7793, IPF19598.1, IPF19599.1, orf6.659,
FT orf6.940, CA0234"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(443644..446541)
FT /gene="orf19.1541"
FT /Ca19Contig="Ca19-10119|complement(206553..209450)"
FT /synonym="orf19.9115, IPF6493, IPF18788.2, IPF6493.2,
FT Contig4-2847_0017, Contig4-2847_0018, orf6.2304, orf6.821,
FT CA0193"
FT /remarks="Protein not essential for viability;
FT transcription is repressed in response to alpha pheromone
FT in SpiderM medium"
FT CDS complement(448930..450738)
FT /gene="orf19.1542"
FT /Ca19Contig="Ca19-10119|complement(211839..213647)"
FT /synonym="orf19.9116, IPF25764.1, IPF6497.2, Contig4-
FT 2847_0014, orf6.6400, CA3970"
FT /remarks="Protein similar to S. cerevisiae Hex3p, which is
FT involved in DNA damage response; transposon mutation
FT affects filamentous growth"
FT CDS complement(451610..452911)
FT /gene="orf19.1543"
FT /Ca19Contig="Ca19-10119|complement(214519..215820)"
FT /synonym="orf19.9117, orf6.6401, IPF6498, IPF25784.1,
FT IPF6498.2, Contig4-2847_0013, CA3971"
FT /remarks="Functional homolog of S. cerevisiae Opi1p, which
FT is a transcriptional repressor of INO1 involved in
FT inositol biosynthesis; has leucine zipper and putative
FT Opi1-Sin3 interaction domain; interacts with ScSin3p, but
FT not CaSin3p "
FT CDS 455718..456515
FT /gene="orf19.1544"
FT /Ca19Contig="Ca19-10119|218627..219424"
FT /synonym="orf19.9118, IPF6504.2, IPF29417.1, Contig4-
FT 2788_0007, Contig4-2847_0005, orf6.6402, CA3972"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(456624..457091)
FT /gene="orf19.1545"
FT /Ca19Contig="Ca19-10119|complement(219533..220000)"
FT /synonym="orf19.9119, IPF25834.1, IPF6505.2, Contig4-
FT 2847_0004, orf6.6403, CA3973"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 457403..458281
FT /gene="orf19.1546"
FT /Ca19Contig="Ca19-10119|220312..221190"
FT /synonym="orf19.9120, IPF25799.1, IPF6507.2, Contig4-
FT 2847_0002, orf6.6404, CA3974"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(458302..459207)
FT /gene="orf19.1547"
FT /Ca19Contig="Ca19-10119|complement(221211..222116)"
FT /synonym="orf19.9121, IPF25796.1, IPF20152.1, Contig4-
FT 2847_0001, orf6.6405, CA3975"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 459259..459990
FT /gene="orf19.1548"
FT /Ca19Contig="Ca19-10119|222168..222899"
FT /synonym="orf19.9122, IPF25806.1, IPF15310.2, orf6.6406,
FT CA3976"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 460412..461158
FT /gene="orf19.1549"
FT /Ca19Contig="Ca19-10119|223321..224067"
FT /synonym="orf19.9123, IPF25802.1, IPF20153.1, Contig4-
FT 2092_0006, orf6.6407, CA3977"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT repressed by nitric oxide; identified in detergent-
FT resistant membrane fraction (possible lipid raft
FT component); predicted transmembrane helix"
FT CDS complement(986523..987557)
FT /gene="orf19.155"
FT /Ca19Contig="Ca19-10037|complement(17693..18727)"
FT /synonym="orf19.7794, IPF15126.2, IPF19196.2, orf6.658,
FT orf6.939, CA0233"
FT /remarks="Functional homolog of S. cerevisiae Ure2p, which
FT is a regulator of nitrogen utilization, and which also has
FT a prion form called [URE3]"
FT CDS 461789..462292
FT /gene="orf19.1551"
FT /Ca19Contig="Ca19-10119|224698..225201"
FT /synonym="orf19.9125, IPF25828.1, IPF20155.1, Contig4-
FT 2163_0001, orf6.6409"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(461464..462039)
FT /gene="orf19.1552"
FT /Ca19Contig="Ca19-10119|complement(224373..224948)"
FT /synonym="orf19.9126, IPF25810.1, IPF20154.1, Contig4-
FT 2092_0004, orf6.6410, CA3978"
FT /remarks="Protein described as a peptidyl-prolyl cis-trans
FT isomerase; macrophage-induced protein"
FT CDS join(complement(463925..464000),complement(463651..463838),
FT complement(462551..463636))
FT /gene="orf19.1553"
FT /Ca19Contig="Ca19-10119|complement(join(226834..226909,2266
FT 76..226747,225460..226487))"
FT /synonym="orf19.9127, IPF25779.1, IPF25794.1, IPF25744.1,
FT IPF7129.2, IPF7127.2, IPF7128.2, Contig4-2092_0009,
FT Contig4-2163_0004, orf6.6411, CA3979"
FT /remarks="Putative protein of unknown function, induced
FT during the mating process; transcription is upregulated in
FT an RHE model of oral candidiasis"
FT CDS join(complement(465609..468329),
FT complement(464660..465607))
FT /gene="orf19.1555"
FT /Ca19Contig="Ca19-10119|complement(join(228518..231238,2275
FT 69..228516))"
FT /synonym="orf19.9129, IPF7130.2, IPF29415.1, IPF18010.3,
FT Contig4-2824_0019, Contig4-2824_0021, orf6.355, orf6.6413,
FT CA6258, CA3982, orf19.1556"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(468692..469534)
FT /gene="orf19.1557"
FT /Ca19Contig="Ca19-10119|complement(231601..232443)"
FT /synonym="orf19.9130, IPF7133.1, IPF19325.2, Contig4-
FT 2824_0012, Contig4-2824_0014, orf6.356, orf6.6414, CA3983"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(469732..470829)
FT /gene="orf19.1559"
FT /Ca19Contig="Ca19-10119|complement(232641..233738)"
FT /synonym="orf19.9132, IPF7136.1, IPF29412.1, Contig4-
FT 2824_0011, orf6.6416, CA3984"
FT /remarks="Putative aspartate-semialdehyde dehydrogenase;
FT fungal-specific (no human or murine homolog); ketoconazole-
FT repressed"
FT CDS complement(988753..990777)
FT /gene="orf19.156"
FT /Ca19Contig="Ca19-10037|complement(19924..21948)"
FT /synonym="orf19.7795, orf19.7796, orf19.7825, IPF27149.1,
FT IPF15128.2, IPF27152.1, IPF15129.1, IPF16389.1,
FT IPF19828.2, Contig4-1770_0004, orf6.938, orf6.937,
FT orf6.1144, orf6.196, CA0232, CA6168, CA0335, orf19.157,
FT orf19.195"
FT /remarks="Protein lacking an ortholog in S. cerevisiae;
FT transposon mutation affects filamentous growth"
FT CDS 471364..472980
FT /gene="orf19.1560"
FT /Ca19Contig="Ca19-10119|234273..235889"
FT /synonym="orf19.9133, IPF25771.1, IPF7138.2, Contig4-
FT 2824_0009, orf6.6417, CA3985"
FT /remarks="Protein similar to S. cerevisiae Pob3p, which is
FT involved in chromatin assembly and disassembly; transposon
FT mutation affects filamentous growth"
FT CDS 474806..475348
FT /gene="orf19.1562"
FT /Ca19Contig="Ca19-10119|237715..238257"
FT /synonym="orf19.9135, IPF25811.1, IPF7141.1, Contig4-
FT 2824_0006, orf6.6419, CA3986"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT transcription is repressed in response to alpha pheromone
FT in SpiderM medium"
FT CDS 476774..478414
FT /gene="orf19.1563"
FT /Ca19Contig="Ca19-10119|239683..241323"
FT /synonym="orf19.9136, IPF25768.1, IPF7144.2, Contig4-
FT 2824_0004, orf6.6420, CA3987"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 478814..479383
FT /gene="orf19.1564"
FT /Ca19Contig="Ca19-10119|241723..242292"
FT /synonym="orf19.9137, IPF25819.1, IPF7145.2, Contig4-
FT 2824_0002, orf6.6421, CA3988"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(479463..481304)
FT /gene="orf19.1565"
FT /Ca19Contig="Ca19-10119|complement(242372..244213)"
FT /synonym="orf19.9138, IPF25756.1, IPF7147.2, Contig4-
FT 2824_0022, orf6.6422, CA3989"
FT /remarks="Putative transcription factor with zinc finger
FT DNA-binding motif"
FT CDS 481528..484356
FT /gene="orf19.1566"
FT /Ca19Contig="Ca19-10119|244437..247265"
FT /synonym="orf19.9139, IPF25737.1, IPF14782.2, Contig4-
FT 2110_0005, Contig4-2110_0006, orf6.6423, CA3990"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS join(484680..486335,486339..487784)
FT /gene="orf19.1567"
FT /Ca19Contig="Ca19-10119|join(247589..249244,249248..250693)
FT "
FT /synonym="orf19.9140, orf19.9141, IPF25780.1, IPF25769.1,
FT IPF19794.1, IPF14783.2, Contig4-2110_0002, Contig4-
FT 2110_0004, orf6.6424, orf6.6425, CA3991, CA3992,
FT orf19.1568"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(488016..491543)
FT /gene="orf19.1569"
FT /Ca19Contig="Ca19-10119|complement(250925..254452)"
FT /synonym="orf19.9142, IPF8275.2, IPF29445.1, Contig4-
FT 2925_0002, Contig4-2925_0003, Contig4-2925_0005,
FT orf6.6426, CA3993"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT decreased expression observed in an ssr1 homozygous null
FT mutant"
FT CDS 491986..494172
FT /gene="orf19.1570"
FT /Ca19Contig="Ca19-10119|254895..257081"
FT /synonym="orf19.9143, IPF8270.1, IPF19258.2, Contig4-
FT 2925_0007, orf6.480, orf6.6427, CA3994"
FT /remarks="2,3-epoxysqualene-lanosterol cyclase (lanosterol
FT synthase), catalyzes the conversion of 2,3-oxidosqualene
FT to lanosterol in sterol biosynthesis; fluconazole-induced"
FT CDS join(complement(494912..495281),
FT complement(494431..494843))
FT /gene="orf19.1571"
FT /Ca19Contig="Ca19-10119|complement(join(257789..258190,2573
FT 40..257789))"
FT /synonym="orf19.9144, orf19.9145, IPF18269.2, IPF25857.1,
FT IPF8269.2, IPF8268.2, Contig4-2925_0009, Contig4-
FT 2925_0010, orf6.479, orf6.6428, orf6.478, CA0091,
FT orf19.1572"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(496774..500826)
FT /gene="orf19.1573"
FT /Ca19Contig="Ca19-10119|complement(259683..263735)"
FT /synonym="orf19.9146, IPF8267.2, IPF29441.1, Contig4-
FT 2925_0014, orf6.1885, orf6.477, CA0761"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 501360..503126
FT /gene="orf19.1574"
FT /Ca19Contig="Ca19-10119|264269..266035"
FT /synonym="orf19.9147, IPF15686.2, IPF29407.1, Contig4-
FT 2925_0020, orf6.1886, CA0762"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 503521..504483
FT /gene="orf19.1575"
FT /Ca19Contig="Ca19-10119|266430..267392"
FT /synonym="orf19.9148, IPF15685.2, IPF9631.1, Contig4-
FT 2410_0006, orf6.1887, orf6.5345, CA3168"
FT /remarks="Phosphoribosylpyrophosphate synthetase; enzyme
FT of purine, pyrimidine, histidine, and tryptophan
FT biosynthesis; essential; flucytosine induced;
FT macrophage/pseudohyphal-induced"
FT CDS 504904..506772
FT /gene="orf19.1576"
FT /Ca19Contig="Ca19-10119|267813..269681"
FT /synonym="orf19.9149, IPF25763.1, IPF9632.2, Contig4-
FT 2410_0005, orf6.5344, CA3167"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 507876..509204
FT /gene="orf19.1577"
FT /Ca19Contig="Ca19-10119|270785..272113"
FT /synonym="orf19.9150, IPF25781.1, IPF9634.1, Contig4-
FT 3005_0030, orf6.5343, CA3166"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 509572..514740
FT /gene="orf19.1578"
FT /Ca19Contig="Ca19-10119|272481..277649"
FT /synonym="orf19.9151, IPF25824.1, IPF9638.2, Contig4-
FT 3005_0028, Contig4-3005_0029, orf6.5342, CA3165"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(515097..517208)
FT /gene="orf19.1580"
FT /Ca19Contig="Ca19-10119|complement(278006..280117)"
FT /synonym="orf19.9153, IPF25755.1, IPF13187.2, Contig4-
FT 3005_0023, Contig4-3005_0025, orf6.5340, CA3164"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 517842..518174
FT /gene="orf19.1581"
FT /Ca19Contig="Ca19-10119|280751..281083"
FT /synonym="orf19.9154, IPF29446.1, orf6.5339"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS join(519237..519833,519900..520964)
FT /gene="orf19.1582"
FT /Ca19Contig="Ca19-10119|join(282146..282757,282761..283873)
FT "
FT /synonym="orf19.9155, orf19.9156, IPF25814.1, IPF25792.1,
FT IPF13183.2, IPF13181.2, Contig4-3005_0018, Contig4-
FT 3005_0019, orf6.5337, orf6.5338, CA3163, CA3162,
FT orf19.1583"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 521289..522821
FT /gene="orf19.1584"
FT /Ca19Contig="Ca19-10119|284198..285730"
FT /synonym="orf19.9157, IPF25774.1, IPF13121.2, Contig4-
FT 3005_0016, orf6.5336, CA3161"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; shows
FT colony morphology-related gene regulation by Ssn6p"
FT CDS 524204..525316
FT /gene="orf19.1585"
FT /Ca19Contig="Ca19-10119|287113..288225"
FT /synonym="orf19.9158, IPF25789.1, IPF13128.2, Contig4-
FT 3005_0008, orf6.5335, CA3160"
FT /remarks="Protein described as predicted zinc transporter;
FT ciclopirox olamine, fluconazole, or alkaline
FT downregulated; transcriptionally induced by interaction
FT with macrophage; amphotericin B induced"
FT CDS complement(525723..526610)
FT /gene="orf19.1586"
FT /Ca19Contig="Ca19-10119|complement(288632..289519)"
FT /synonym="orf19.9159, IPF25798.1, IPF13130.2, Contig4-
FT 3005_0005, orf6.5334, CA3159"
FT /remarks="Putative phosphatidylinositol-specific
FT phospholipase C (PI-PLC); predicted type 2 membrane
FT protein; no S. cerevisiae ortholog; role in, and regulated
FT by, filamentation; no mouse systemic virulence role;
FT almost identical to orf19.5797"
FT CDS complement(527010..528521)
FT /gene="orf19.1587"
FT /Ca19Contig="Ca19-10119|complement(289919..291430)"
FT /synonym="orf19.9160, IPF25777.1, IPF13131.2, Contig4-
FT 3005_0004, orf6.5333, CA3158"
FT /remarks="Putative glucose transporter of the major
FT facilitator superfamily; the C. albicans glucose
FT transporter family comprises 20 members; 12 probable
FT membrane-spanning segments; regulated by Nrg1p"
FT CDS 529260..529679
FT /gene="orf19.1588"
FT /Ca19Contig="Ca19-10119|292169..292588"
FT /synonym="orf19.9161, IPF25850.1, IPF14456.2, Contig4-
FT 3005_0003, orf6.5332, CA3157"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 530218..531531
FT /gene="orf19.1589"
FT /Ca19Contig="Ca19-10119|293127..294440"
FT /synonym="orf19.9162, IPF25783.1, IPF14455.1, Contig4-
FT 3005_0002, orf6.5331, CA3156"
FT /remarks="Putative DNA-binding transcription factor"
FT CDS join(903971..904504,904506..905750)
FT /gene="orf19.1590"
FT /Ca19Contig="Ca19-1800|complement(17..1492)"
FT /synonym="IPF13333.3, orf6.1068, CA0289"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 902545..903753
FT /gene="orf19.1591"
FT /Ca19Contig="Ca19-1800|complement(1635..2843)"
FT /synonym="IPF13331.2, orf6.1069, CA0290"
FT /remarks="Protein similar to acetyl-CoA acetyltransferase;
FT role in ergosterol biosynthesis; soluble in hyphae;
FT changes in protein abundance associated with azole
FT resistance; fluconazole or ketoconazole induced;
FT macrophage-downregulated protein"
FT CDS complement(900967..901725)
FT /gene="orf19.1592"
FT /Ca19Contig="Ca19-1800|3663..4421"
FT /synonym="IPF13328.2, orf6.1070, CA0291"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1913550..1914416
FT /gene="orf19.1597"
FT /Ca19Contig="Ca19-10122|83..652"
FT /synonym="orf19.9165, IPF25726.1, IPF3765.3, Contig4-
FT 3095_0044, orf6.1085, CA0299"
FT /remarks="Vacuolar membrane protein; depletion causes
FT abnormal vacuolar morphology, cell separation defect,
FT sensitivity to cell wall perturbation, and increased
FT hyphal branching; essential gene with no mammalian
FT homolog; Cyr1p-regulated"
FT CDS complement(1914555..1915952)
FT /gene="orf19.1598"
FT /Ca19Contig="Ca19-10122|complement(792..2138)"
FT /synonym="orf19.9166, IPF25723.1, IPF3764.2, Contig4-
FT 3095_0045, orf6.1086, orf6.1911, CA0300"
FT /remarks="C-14 sterol reductase, has a role in ergosterol
FT biosynthesis"
FT CDS 1919332..1919688
FT /gene="orf19.1599"
FT /Ca19Contig="Ca19-10122|5518..5874"
FT /synonym="orf19.9167, IPF3759.2, IPF29393.1, Contig4-
FT 3095_0048, orf6.1648"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1920541..1922670
FT /gene="orf19.1600"
FT /Ca19Contig="Ca19-10122|6727..8856"
FT /synonym="orf19.9168, IPF25722.1, IPF19700.1, Contig4-
FT 3095_0049, Contig4-3095_0051, orf6.1649, CA0614"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1923194..1924363
FT /gene="orf19.1601"
FT /Ca19Contig="Ca19-10122|9380..10549"
FT /synonym="orf19.9169, IPF25724.1, IPF6742.1, Contig4-
FT 3095_0054, orf6.1650, CA0615"
FT /remarks="Putative ribosomal protein; similar to S.
FT cerevisiae Rpl3p; gene induced by ciclopirox olamine
FT treatment; genes encoding cytoplasmic ribosomal subunits
FT are downregulated upon phagocytosis by murine macrophage"
FT CDS join(complement(1934730..1934775),
FT complement(1934463..1934494),complement(1931570..1934449))
FT /gene="orf19.1604"
FT /Ca19Contig="Ca19-10122|complement(17756..20506)"
FT /synonym="orf19.9172, IPF25717.1, IPF6730.2, Contig4-
FT 3095_0062, Contig4-3095_0063, orf6.2453, CA1121"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; Gal4p-
FT like DNA-binding domain"
FT CDS join(complement(1938965..1940611),
FT complement(1937878..1938963))
FT /gene="orf19.1605"
FT /Ca19Contig="Ca19-10122|complement(24064..26394)"
FT /synonym="orf19.9173, IPF25719.1, IPF6724.1, Contig4-
FT 3095_0066, orf6.2454, CA1122"
FT /remarks="Protein described as DNA mismatch repair factor;
FT ortholog of S. cerevisiae PMS1 which is an ATP-binding
FT protein involved in DNA mismatch repair"
FT CDS complement(1301777..1302361)
FT /gene="orf19.17"
FT /Ca19Contig="Ca19-10014|complement(277..861)"
FT /synonym="orf19.7688, IPF3874.2, IPF29979.1, CA6167"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT constitutive expression independent of MTL or white-opaque
FT status"
FT CDS complement(2138797..2139819)
FT /gene="orf19.1742"
FT /Ca19Contig="Ca19-10125|233..1255"
FT /synonym="orf19.9309, orf6.1095, IPF25565.1, IPF15629.3,
FT Contig4-2299_0001, Contig4-2299_0002, CA0306"
FT /remarks="Hydroxymethylbilane synthase (uroporphyrinogen I
FT synthase); catalyzes conversion of 4-porphobilinogen to
FT hydroxymethylbilane, the third step in the heme
FT biosynthetic pathway; transcription greater in high iron,
FT CO2; alkaline downregulated"
FT CDS join(complement(2134911..2135633),
FT complement(2133605..2134909))
FT /gene="orf19.1743"
FT /Ca19Contig="Ca19-10125|4419..6446"
FT /synonym="orf19.9310, IPF25554.1, IPF15005.2, Contig4-
FT 2199_0001, orf6.2015, CA0848"
FT /remarks="Putative acetyl-CoA synthetase, similar to S.
FT cerevisiae Acs2p; upregulated in the presence of human
FT neutrophils; fluconazole-downregulated; regulated by Nrg1p
FT and Mig1p; shows colony morphology-related gene regulation
FT by Ssn6p"
FT CDS 2132527..2133342
FT /gene="orf19.1744"
FT /Ca19Contig="Ca19-10125|complement(6709..7524)"
FT /synonym="orf19.9311, orf6.2016, orf6.69, IPF15006.2,
FT IPF19454.2, Contig4-2199_0003, CA0849"
FT /remarks="Protein described as uroporphyrinogen III
FT synthase; transcriptionally regulated by iron; expression
FT greater in high iron or elevated CO2; alkaline
FT downregulated"
FT CDS complement(2130768..2131262)
FT /gene="orf19.1745"
FT /Ca19Contig="Ca19-10125|8789..9283"
FT /synonym="orf19.9312, IPF16671.1, IPF15008.3, Contig4-
FT 2199_0006, orf6.2017, orf6.70, CA0850"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT possibly spurious ORF (Annotation Working Group
FT prediction)"
FT CDS complement(2129183..2130508)
FT /gene="orf19.1746"
FT /Ca19Contig="Ca19-10125|9543..10868"
FT /synonym="orf19.9313, IPF16670.2, IPF10753.2, Contig4-
FT 2199_0007, orf6.2018, orf6.85, CA0851, Ca38F10.06"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT similar to S. cerevisiae meiosis-specific, spore-wall-
FT localized protein Ssp2p, which is required for wild-type
FT formation of outer spore wall in S. cerevisiae"
FT CDS complement(2126805..2128802)
FT /gene="orf19.1747"
FT /Ca19Contig="Ca19-10125|11249..13246"
FT /synonym="orf19.9315, IPF10752.2, IPF16668.3, Contig4-
FT 2591_0011, orf6.2020, orf6.86, CA0852"
FT /remarks="Protein similar to S. cerevisiae Kip2p;
FT transcription is repressed in response to alpha pheromone
FT in SpiderM medium"
FT CDS complement(2124189..2126234)
FT /gene="orf19.1748"
FT /Ca19Contig="Ca19-10125|13817..15862"
FT /synonym="orf19.9316, IPF19639.1, IPF19640.2, Contig4-
FT 2591_0004, orf6.1825, orf6.2021, CA0853"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; shows
FT colony morphology-related gene regulation by Ssn6p"
FT CDS join(2122326..2122402,2123245..2123959)
FT /gene="orf19.1750"
FT /Ca19Contig="Ca19-10125|complement(15983..16582)"
FT /synonym="orf19.9319, IPF25570.1, IPF10745.2, Contig4-
FT 2591_0005, Contig4-2591_0006, orf6.1827"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT similar to mammalian SR-like RNA splicing factor; gene has
FT intron; significant changes made to ORF with coordinate
FT updates (see Locus History)"
FT CDS complement(2118427..2120655)
FT /gene="orf19.1751"
FT /Ca19Contig="Ca19-10125|19396..21624"
FT /synonym="orf19.9320, IPF25551.1, IPF10741.2, orf6.1080,
FT orf6.1828, CA0726"
FT /remarks="Protein involved in regulation of unsaturated
FT fatty acid biosynthesis; controls the expression of the
FT Ole1p delta-9-fatty acid desaturase"
FT CDS 2115865..2118144
FT /gene="orf19.1753"
FT /Ca19Contig="Ca19-10125|complement(21907..24186)"
FT /synonym="orf19.9322, IPF16061.2, IPF6867.2, Contig4-
FT 2851_0001, orf6.1078, orf6.4096, CA0294"
FT /remarks="Protein similar to S. cerevisiae tRNA
FT modification protein; induced upon biofilm formation"
FT CDS complement(2113772..2115205)
FT /gene="orf19.1754"
FT /Ca19Contig="Ca19-10125|24846..26279"
FT /synonym="orf19.9323, IPF16060.2, IPF6866.1, Contig4-
FT 2851_0003, orf6.1077, orf6.4095, CA2265"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(2110669..2113203)
FT /gene="orf19.1755"
FT /Ca19Contig="Ca19-10125|26848..29382"
FT /synonym="orf19.9324, IPF25548.1, IPF6862.2, Contig4-
FT 2851_0005, Contig4-2851_0006, orf6.4094, CA2264"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 2109191..2110402
FT /gene="orf19.1756"
FT /Ca19Contig="Ca19-10125|complement(29649..30860)"
FT /synonym="orf19.9325, IPF25561.1, IPF6860.1, Contig4-
FT 2851_0007, orf6.4093, CA2263"
FT /remarks="Protein similar to S. cerevisiae glycerol-3-
FT phosphate dehydrogenase (enzyme of glycerol biosynthesis);
FT biofilm-induced expression; regulated by Efg1p; regulated
FT by Tsa1p, Tsa1Bp under H2O2 stress conditions"
FT CDS 2104278..2106029
FT /gene="orf19.1757"
FT /Ca19Contig="Ca19-10125|complement(34022..35773)"
FT /synonym="orf19.9326, IPF25560.1, IPF6857.1, Contig4-
FT 2851_0019, orf6.4092, CA2262"
FT /remarks="Putative transcription factor with zinc finger
FT DNA-binding motif; transcription is upregulated in
FT clinical isolates from HIV+ patients with oral
FT candidiasis"
FT CDS complement(2100502..2101950)
FT /gene="orf19.1759"
FT /Ca19Contig="Ca19-10125|38101..39549"
FT /synonym="orf19.9328, IPF6854.2, IPF29313.1, Contig4-
FT 1958_0002, orf6.4090, orf6.925, CA0227"
FT /remarks="Protein not essential for viability; similar to
FT S. cerevisiae Pho23p, which is a probable component of the
FT Rpd3 histone deacetylase complex"
FT CDS complement(2098082..2098957)
FT /gene="orf19.1760"
FT /Ca19Contig="Ca19-10125|41094..41969"
FT /synonym="orf19.9329, IPF25567.1, IPF6849.2, Contig4-
FT 1964_0005, orf6.4089, CA2261"
FT /remarks="RAS signal transduction GTPase; regulates cAMP
FT and MAP kinase pathways; role in hyphal induction,
FT virulence, apoptosis, heat-shock sensitivity;
FT nonessential; glutamine-rich C terminus; complements
FT viability of S. cerevisiae ras1 ras2 mutant"
FT CDS 2097182..2097697
FT /gene="orf19.1761"
FT /Ca19Contig="Ca19-10125|complement(42354..42869)"
FT /synonym="orf19.9330, IPF25572.1, IPF6848.1, Contig4-
FT 1964_0004, orf6.4088, CA2260"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(2096027..2096836)
FT /gene="orf19.1762"
FT /Ca19Contig="Ca19-10125|43215..44024"
FT /synonym="orf19.9331, IPF25568.1, IPF6845.2, Contig4-
FT 1964_0001, orf6.4087, CA2259"
FT /remarks="Protein not essential for viability"
FT CDS 2094712..2095824
FT /gene="orf19.1763"
FT /Ca19Contig="Ca19-10125|complement(44227..45339)"
FT /synonym="orf19.9332, IPF17558.3, IPF17956.2, orf6.4086,
FT CA2258"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT induced by nitric oxide"
FT CDS complement(2091926..2092774)
FT /gene="orf19.1764"
FT /Ca19Contig="Ca19-10125|47277..48125"
FT /synonym="orf19.9333, IPF16551.2, IPF29314.1, Contig4-
FT 2450_0007, orf6.2873, orf6.4085, CA6192"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 2090174..2091430
FT /gene="orf19.1765"
FT /Ca19Contig="Ca19-10125|complement(48621..49877)"
FT /synonym="orf19.9334, IPF19560.1, IPF19561.2, Contig4-
FT 2450_0006, orf6.189, orf6.2872, CA1394"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 2085854..2087059
FT /gene="orf19.1766"
FT /Ca19Contig="Ca19-10125|complement(52992..54197)"
FT /synonym="orf19.9335, IPF25563.1, IPF6146.2, Contig4-
FT 2031_0001, orf6.2871, CA1393"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 2082613..2084454
FT /gene="orf19.1767"
FT /Ca19Contig="Ca19-10125|complement(55597..57438)"
FT /synonym="orf19.9336, IPF25557.1, IPF6149.2, Contig4-
FT 2062_0005, Contig4-2062_0006, orf6.2870, CA1392"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS join(2078457..2080484,2080488..2081591)
FT /gene="orf19.1768"
FT /Ca19Contig="Ca19-10125|complement(join(59567..61594,58460.
FT .59563))"
FT /synonym="orf19.9337, IPF25564.1, IPF25556.1, IPF6151.2,
FT IPF17474.2, Contig4-1661_0001, Contig4-2062_0011,
FT orf6.2869, CA1390"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 2077203..2078000
FT /gene="orf19.1769"
FT /Ca19Contig="Ca19-10125|complement(62051..62848)"
FT /synonym="orf19.9338, IPF17476.2, IPF17425.2, Contig4-
FT 1661_0003, orf6.245, orf6.2868, CA1389"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 2076138..2076470
FT /gene="orf19.1770"
FT /Ca19Contig="Ca19-10125|complement(63581..63913)"
FT /synonym="orf19.9339, orf6.244, IPF25577.1, IPF17424.2,
FT Contig4-1661_0006, CA0038"
FT /remarks="Cytochrome c; complements defects of an S.
FT cerevisiae cyc1 cyc7 double mutant; transcriptionally
FT regulated by iron; expression greater in high iron;
FT alkaline downregulated; repressed by nitric oxide"
FT CDS 2073086..2075032
FT /gene="orf19.1771"
FT /Ca19Contig="Ca19-10125|complement(65019..66965)"
FT /synonym="orf19.9340, IPF16269.2, IPF29311.1, Contig4-
FT 1714_0001, Contig4-1714_0002, orf6.1677, CA0633"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(2069962..2072916)
FT /gene="orf19.1772"
FT /Ca19Contig="Ca19-10125|67135..70089"
FT /synonym="orf19.9341, IPF25546.1, IPF16267.2, Contig4-
FT 1808_0003, orf6.1678, CA0634"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 2068361..2069650
FT /gene="orf19.1773"
FT /Ca19Contig="Ca19-10125|complement(70401..71690)"
FT /synonym="orf19.9342, IPF9036.2, IPF19909.2, Contig4-
FT 2933_0003, orf6.1679, orf6.2661, CA0635"
FT /remarks="Protein similar to (but shorter than) S.
FT cerevisiae Rap1p, a transcriptional regulator that binds
FT telomeres and regulatory sequences; binds DNA; represses
FT hyphal growth under yeast-favoring conditions"
FT CDS join(2066224..2066587,2066653..2067368)
FT /gene="orf19.1774"
FT /Ca19Contig="Ca19-10125|complement(join(73464..73827,72683.
FT .73398))"
FT /synonym="IPF9033.1, IPF9034.1, Contig4-2728_0003,
FT orf6.2662, orf6.2663, CA1253, CA1254, orf19.1775"
FT /remarks="Putative protein of unknown function,
FT transcription is upregulated in an RHE model of oral
FT candidiasis; predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(2063777..2064745)
FT /gene="orf19.1776"
FT /Ca19Contig="Ca19-10125|75306..76274"
FT /synonym="orf19.9343, IPF25566.1, IPF9030.2, Contig4-
FT 2728_0006, orf6.2664, CA1255"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 2059475..2063623
FT /gene="orf19.1777"
FT /Ca19Contig="Ca19-10125|complement(76428..80576)"
FT /synonym="orf19.9344, IPF25575.1, IPF9029.2, Contig4-
FT 2728_0007, orf6.2665, CA1256"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 2057638..2057952
FT /gene="orf19.1778"
FT /Ca19Contig="Ca19-10125|complement(82099..82413)"
FT /synonym="IPF15902.2, orf6.2666"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(2054929..2056065)
FT /gene="orf19.1779"
FT /Ca19Contig="Ca19-10125|84804..85121"
FT /synonym="orf19.9345, IPF15898.1, IPF9023.3, Contig4-
FT 1875_0004, orf6.2667, CA0156"
FT /remarks="Cell surface mannoprotein; mycelial antigen;
FT possible role in cell-wall glucan metabolism; has adhesin
FT motif; O-glycosylation but no predicted N-glycosylation;
FT induced by heat, upon germ tube formation, wall
FT regeneration; diagnostic marker"
FT CDS complement(2052049..2053287)
FT /gene="orf19.1780"
FT /Ca19Contig="Ca19-10125|86763..88001"
FT /synonym="orf19.9346, IPF25562.1, IPF16648.1, Contig4-
FT 1793_0004, orf6.2527, CA1166"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(2050962..2051681)
FT /gene="orf19.1782"
FT /Ca19Contig="Ca19-10125|88369..89088"
FT /synonym="orf19.9348, IPF16210.3, IPF16646.2, Contig4-
FT 1793_0006, Contig4-2624_0009, orf6.2529, CA1167"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS join(complement(2046625..2048772),
FT complement(2044306..2046612))
FT /gene="orf19.1783"
FT /Ca19Contig="Ca19-10125|join(91278..93425,93438..95744)"
FT /synonym="orf19.9349, orf19.9350, IPF16207.2, IPF25550.1,
FT IPF13015.2, IPF13016.2, Contig4-2624_0003, Contig4-
FT 2624_0004, orf6.2530, orf6.2531, orf6.531, CA6193, CA6194,
FT orf19.1784"
FT /remarks="Protein similar to S. cerevisiae Yor1p, which is
FT a plasma membrane transporter of the ATP-binding cassette
FT (ABC) family involved in resistance to aureobasidin A;
FT transcription is specific to white cell type"
FT CDS 2043032..2044012
FT /gene="orf19.1785"
FT /Ca19Contig="Ca19-10125|complement(96038..97018)"
FT /synonym="orf19.9351, IPF13018.3, IPF13017.2, Contig4-
FT 2624_0006, orf6.214, orf6.2532, CA1168"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS join(complement(1304207..1304657),
FT complement(1302845..1303959))
FT /gene="orf19.18"
FT /Ca19Contig="Ca19-10014|complement(join(2654..3104,1292..24
FT 06))"
FT /synonym="orf19.7689, orf19.7690, IPF3873.2, IPF27224.1,
FT IPF29977.1, IPF3872.2, orf6.2651, orf6.2652, CA1246,
FT orf19.19"
FT /remarks="Inosine monophosphate (IMP) dehydrogenase;
FT enzyme of GMP biosynthesis; target of mycophenolic acid
FT and mizoribine monophosphate; antigenic during human or
FT murine infection; soluble protein in hyphae; downregulated
FT in core stress response"
FT CDS join(1008769..1009854,1009856..1009957,1009960..1010178)
FT /gene="orf19.182"
FT /Ca19Contig="Ca19-10044|complement(join(1400..2587,1179..13
FT 97))"
FT /synonym="orf19.7812, IPF27133.1, IPF27131.1, IPF13421.3,
FT IPF19396.1, Contig4-2218_0006, orf6.195, orf6.944, CA0029"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1007851..1008519
FT /gene="orf19.183"
FT /Ca19Contig="Ca19-10044|complement(2837..3505)"
FT /synonym="orf19.7813, IPF13420.2, IPF19395.2, Contig4-
FT 2218_0007, orf6.945, CA0235"
FT /remarks="Imidazoleglycerol-phosphate dehydratase, enzyme
FT of histidine biosynthesis; functionally complements S.
FT cerevisiae his3-1 mutation; hyphal-induced expression;
FT regulated by Gcn2p and Gcn4p; fungal-specific (no human or
FT murine homolog)"
FT CDS complement(1005990..1007411)
FT /gene="orf19.184"
FT /Ca19Contig="Ca19-10044|3945..5366"
FT /synonym="orf19.7814, IPF13419.2, IPF29930.1, Contig4-
FT 1757_0003, orf6.2957, orf6.946, CA0236"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1004628..1005734)
FT /gene="orf19.185"
FT /Ca19Contig="Ca19-10044|5622..6728"
FT /synonym="orf19.7816, IPF13418.1, IPF13417.3, Contig4-
FT 1757_0005, orf6.2958, orf6.948, CA1445"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1561140..1562540)
FT /gene="orf19.1860.1"
FT /Ca19Contig="Ca19-10135|1..1359"
FT /synonym="orf19.9762, IPF25116.1, IPF4072.2, orf6.1260,
FT orf6.4262, CA2380, orf19.2217"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1559164..1561038
FT /gene="orf19.1861"
FT /Ca19Contig="Ca19-10135|complement(1461..3335)"
FT /synonym="orf19.9417, orf19.9763, IPF25427.1, IPF4071.2,
FT IPF25109.1, IPF29169.1, orf6.1261, orf6.4263, CA0385,
FT orf19.2218"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1557451..1557786)
FT /gene="orf19.1862"
FT /Ca19Contig="Ca19-10135|4715..5080"
FT /synonym="orf19.9418, IPF4065, orf6.1262, IPF18208.2,
FT IPF4065.1, Contig4-2502_0004, CA0386"
FT /remarks="Possible stress protein; increased transcription
FT is associated with CDR1 and CDR2 overexpression or
FT fluphenazine treatment; transcription regulated by Sfu1p,
FT Nrg1p, Tup1p"
FT CDS join(1555533..1556801,1556803..1557321)
FT /gene="orf19.1863"
FT /Ca19Contig="Ca19-10135|complement(5696..6967)"
FT /synonym="orf19.9419, IPF4064.2, IPF19005.1, Contig4-
FT 2502_0003, orf6.1263, orf6.7057, CA4497"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1553064..1555223)
FT /gene="orf19.1864"
FT /Ca19Contig="Ca19-10135|7277..9436"
FT /synonym="orf19.9420, IPF4062.2, IPF19004.2, Contig4-
FT 3010_0027, orf6.1264, orf6.7056, CA4496"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1550765..1552609)
FT /gene="orf19.1865"
FT /Ca19Contig="Ca19-10135|9891..11735"
FT /synonym="orf19.9421, IPF25426.1, IPF4059.1, Contig4-
FT 3010_0001, orf6.7055, CA4495"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1550095..1550436
FT /gene="orf19.1866"
FT /Ca19Contig="Ca19-10135|complement(12064..12405)"
FT /synonym="orf19.9422, IPF25457.1, IPF4056.2, Contig4-
FT 3010_0002, orf6.7054, CA4494"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1548608..1549807
FT /gene="orf19.1867"
FT /Ca19Contig="Ca19-10135|complement(12693..13892)"
FT /synonym="orf19.9423, IPF25437.1, IPF4055.2, Contig4-
FT 3010_0003, Contig4-3010_0005, orf6.7053, CA4493"
FT /remarks="Putative malate permease; induced during
FT macrophage infection; regulated by Gcn2p and Gcn4p; has
FT putative peroxisome targeting signal"
FT CDS 1546939..1548123
FT /gene="orf19.1868"
FT /Ca19Contig="Ca19-10135|complement(14377..15561)"
FT /synonym="orf19.9424, IPF25438.1, IPF4053.1, Contig4-
FT 3010_0006, orf6.7052, CA4492"
FT /remarks="Protein described as ribonucleoside diphosphate
FT reductase; shows colony morphology-related gene regulation
FT by Ssn6p; RNA abundance regulated by tyrosol and cell
FT density"
FT CDS 1003296..1004507
FT /gene="orf19.187"
FT /Ca19Contig="Ca19-10044|complement(6849..8060)"
FT /synonym="orf19.7818, IPF13416.3, IPF18673.1, orf6.2960,
FT orf6.950, CA6314"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1540709..1545634
FT /gene="orf19.1871"
FT /Ca19Contig="Ca19-10135|complement(16866..21791)"
FT /synonym="orf19.9427, IPF4050.2, IPF29275.1, Contig4-
FT 3010_0009, orf6.284, orf6.7049, CA4491"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1539529..1540164
FT /gene="orf19.1872"
FT /Ca19Contig="Ca19-10135|complement(22336..22971)"
FT /synonym="orf19.9428, IPF4045.1, IPF17566.1, Contig4-
FT 3010_0010, orf6.283, orf6.7048, CA4490"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT repressed by nitric oxide"
FT CDS 1538685..1539017
FT /gene="orf19.1873"
FT /Ca19Contig="Ca19-10135|complement(23483..23815)"
FT /synonym="orf19.9429, IPF4044.1, IPF17567.2, Contig4-
FT 3010_0011, orf6.282, orf6.7047"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT repressed by nitric oxide; possibly spurious ORF
FT (Annotation Working Group prediction)"
FT CDS join(complement(1537426..1538040),
FT complement(1536636..1537358))
FT /gene="orf19.1874"
FT /Ca19Contig="Ca19-10135|join(24460..25074,25142..25864)"
FT /synonym="orf19.9430, orf19.9431, IPF4042.2, IPF25446.1,
FT IPF29274.1, IPF4041.1, Contig4-3010_0012, Contig4-
FT 3010_0014, Contig4-3010_0015, orf6.7045, orf6.7046,
FT CA4489, CA4488, orf19.1875"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1535147..1536505)
FT /gene="orf19.1876"
FT /Ca19Contig="Ca19-10135|25995..27353"
FT /synonym="orf19.9432, IPF25435.1, IPF4039.2, Contig4-
FT 3010_0018, orf6.7044, CA4487"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1534335..1535150
FT /gene="orf19.1877"
FT /Ca19Contig="Ca19-10135|complement(27350..28165)"
FT /synonym="orf19.9433, IPF25445.1, IPF9162.2, Contig4-
FT 3010_0019, orf6.7043, CA4486"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1533112..1534083)
FT /gene="orf19.1878"
FT /Ca19Contig="Ca19-10135|28417..29388"
FT /synonym="orf19.9434, IPF25443.1, IPF9160.2, Contig4-
FT 3010_0022, orf6.7042, CA4485"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1002055..1003254
FT /gene="orf19.188"
FT /Ca19Contig="Ca19-10044|complement(8102..9301)"
FT /synonym="IPF13416.3, IPF13410.3, orf6.2961, CA0237"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1531857..1533017
FT /gene="orf19.1880"
FT /Ca19Contig="Ca19-10135|complement(29483..30643)"
FT /synonym="orf19.9436, orf6.7040, IPF25439.1, IPF9158.2,
FT Contig4-3010_0023, Contig4-3010_0024, CA4484"
FT /remarks="Putative ferrochelatase involved in heme
FT biosynthesis; transcription is not regulated by iron
FT levels and is also not affected by a yfh1 null mutation"
FT CDS 1529331..1531139
FT /gene="orf19.1881"
FT /Ca19Contig="Ca19-10135|complement(31361..33169)"
FT /synonym="orf19.9437, IPF25428.1, IPF9156.2, orf6.7039,
FT CA4483"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1525563..1529081
FT /gene="orf19.1883"
FT /Ca19Contig="Ca19-10135|complement(33419..36937)"
FT /synonym="orf19.9439, IPF25461.1, IPF9154.2, Contig4-
FT 2743_0002, orf6.7037, CA4482"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1524189..1525280
FT /gene="orf19.1885"
FT /Ca19Contig="Ca19-10135|complement(37220..38311)"
FT /synonym="orf19.9441, IPF9150.1, IPF29273.1, Contig4-
FT 2743_0004, orf6.7035, CA4481"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1522415..1523530)
FT /gene="orf19.1886"
FT /Ca19Contig="Ca19-10135|38970..40085"
FT /synonym="orf19.9442, IPF25440.1, IPF9148.2, Contig4-
FT 2743_0006, orf6.190, orf6.7034, CA0027"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT essential; downregulated during core stress response; S.
FT cerevisiae ortholog is essential"
FT CDS complement(1520066..1521769)
FT /gene="orf19.1887"
FT /Ca19Contig="Ca19-10135|40731..42434"
FT /synonym="orf19.9443, IPF25430.1, IPF6464.2, Contig4-
FT 2743_0008, orf6.7033, CA4480"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1518177..1519169)
FT /gene="orf19.1888"
FT /Ca19Contig="Ca19-10135|43331..44323"
FT /synonym="orf19.9444, IPF25442.1, IPF6462.1, Contig4-
FT 2743_0009, orf6.7032, CA4479"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1517343..1518065
FT /gene="orf19.1889"
FT /Ca19Contig="Ca19-10135|complement(44435..45157)"
FT /synonym="orf19.9445, IPF25444.1, IPF6461.2, orf6.7031,
FT CA4478"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1515521..1516987
FT /gene="orf19.1890"
FT /Ca19Contig="Ca19-10135|complement(45513..46979)"
FT /synonym="orf19.9446, IPF25432.1, IPF6459.1, orf6.7030,
FT CA4477"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1513026..1514285)
FT /gene="orf19.1891"
FT /Ca19Contig="Ca19-10135|48215..49474"
FT /synonym="orf19.9447, orf6.7029, PRA, IPF25433.1,
FT IPF6456.2, Contig4-2189_0002, CA4476"
FT /remarks="Vacuolar aspartic proteinase; mRNA abundance is
FT equivalent in yeast-form and mycelial cells but is
FT elevated at lower growth temperatures; upregulated in the
FT presence of human neutrophils"
FT CDS complement(1510047..1512416)
FT /gene="orf19.1893"
FT /Ca19Contig="Ca19-10135|50084..52453"
FT /synonym="orf19.9449, IPF25421.1, IPF6455.2, Contig4-
FT 2189_0003, Contig4-2752_0004, Contig4-2752_0005,
FT orf6.7027, CA4475"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1507793..1509739
FT /gene="orf19.1896"
FT /Ca19Contig="Ca19-10135|complement(52761..54707)"
FT /synonym="orf19.9452, IPF25425.1, IPF6450.2, Contig4-
FT 2752_0006, Contig4-2752_0008, orf6.7024, CA4474"
FT /remarks="Heat shock protein; at surface of yeast-form
FT cells, but not hyphae; antigenic; soluble in hyphae; Gcn4p-
FT regulated; induced upon amino acid starvation (3-
FT aminotriazole) or upon adherence to polystyrene;
FT macrophage-downregulated protein"
FT CDS 1506182..1507216
FT /gene="orf19.1897"
FT /Ca19Contig="Ca19-10135|complement(55284..56318)"
FT /synonym="orf19.9453, IPF25441.1, IPF6447.1, Contig4-
FT 2752_0011, orf6.7023, CA4473"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1000936..1001910
FT /gene="orf19.190"
FT /Ca19Contig="Ca19-10044|complement(9446..10420)"
FT /synonym="orf19.7820, IPF27134.1, IPF15052.3, orf6.2963,
FT CA1446"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1504358..1505809
FT /gene="orf19.1900"
FT /Ca19Contig="Ca19-10135|complement(56691..58142)"
FT /synonym="orf19.9456, IPF25434.1, IPF6444.2, Contig4-
FT 2752_0013, orf6.7020, CA4472"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1501451..1504087
FT /gene="orf19.1901"
FT /Ca19Contig="Ca19-10135|complement(58413..61049)"
FT /synonym="orf19.9457, IPF25419.1, IPF9716.2, Contig4-
FT 2752_0015, orf6.7019, CA4471"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1499414..1501102
FT /gene="orf19.1902"
FT /Ca19Contig="Ca19-10135|complement(61398..63086)"
FT /synonym="orf19.9458, IPF25429.1, IPF9717.2, Contig4-
FT 2752_0016, orf6.7018, CA4470"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS join(18819..18920,18922..19149)
FT /gene="orf19.1906"
FT /Ca19Contig="Ca19-10136|complement(487..816)"
FT /synonym="orf19.9462, IPF25415.1, IPF29267.1, orf6.1265"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(15457..17610)
FT /gene="orf19.1907"
FT /Ca19Contig="Ca19-10136|2024..4177"
FT /synonym="orf19.9463, IPF14468, IPF25401.1, IPF14468.2,
FT Contig4-2832_0014, Contig4-2832_0015, orf6.1266, orf6.797,
FT CA0388"
FT /remarks="Protein not essential for viability, induced
FT during the mating process"
FT CDS 997937..1000612
FT /gene="orf19.191"
FT /Ca19Contig="Ca19-10044|complement(10744..13419)"
FT /synonym="orf19.7821, IPF27130.1, IPF15055.2, Contig4-
FT 2639_0001, orf6.2964, CA1447"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT constitutive expression independent of MTL or white-opaque
FT status"
FT CDS 14823..15446
FT /gene="orf19.1910"
FT /Ca19Contig="Ca19-10136|complement(4188..4811)"
FT /synonym="orf19.9466, IPF15444.2, IPF14465.1, Contig4-
FT 2832_0017, orf6.1269, orf6.798, CA0389"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(13261..14415)
FT /gene="orf19.1911"
FT /Ca19Contig="Ca19-10136|5219..6373"
FT /synonym="orf19.9467, IPF15442.1, IPF14463.2, Contig4-
FT 2107_0004, Contig4-2832_0018, orf6.1967, orf6.799, CA0188"
FT /remarks="Putative GPI-anchored protein of unknown
FT function; fluconazole-induced"
FT CDS 12627..13253
FT /gene="orf19.1913"
FT /Ca19Contig="Ca19-10136|complement(6381..7007)"
FT /synonym="orf19.9469, IPF15439.1, IPF16231.2, Contig4-
FT 2107_0003, orf6.1966, orf6.801, CA0815"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(11100..12443)
FT /gene="orf19.1914"
FT /Ca19Contig="Ca19-10136|7191..8534"
FT /synonym="orf19.9470, IPF15437.1, IPF16233.1, Contig4-
FT 2107_0001, orf6.1965, orf6.802, CA0814, AMAN6"
FT /remarks="Induced by mating factor in MTLa/MTLa opaque
FT cells"
FT CDS complement(9360..11063)
FT /gene="orf19.1915"
FT /Ca19Contig="Ca19-10136|8571..10274"
FT /synonym="orf19.9471, IPF19846.2, IPF16234.2, orf6.1964,
FT orf6.803, CA0813"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT downregulated in core stress response"
FT CDS complement(8144..9289)
FT /gene="orf19.1917"
FT /Ca19Contig="Ca19-10136|10345..11490"
FT /synonym="orf19.9473, IPF25402.1, IPF16243.2, orf6.1962,
FT CA0812"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 995512..997215
FT /gene="orf19.192"
FT /Ca19Contig="Ca19-10044|complement(14141..15844)"
FT /synonym="orf19.7822, IPF27132.1, IPF14728.2, Contig4-
FT 2639_0004, Contig4-2639_0005, orf6.2965, CA1448"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(7510..8043)
FT /gene="orf19.1920"
FT /Ca19Contig="Ca19-10136|11591..12124"
FT /synonym="orf19.9476, IPF25405.1, IPF17625.2, orf6.1959,
FT CA0811"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 5665..7335
FT /gene="orf19.1923"
FT /Ca19Contig="Ca19-10136|complement(12299..13969)"
FT /synonym="orf19.9479, IPF19884.2, IPF19708.1, orf6.1957,
FT CA0810"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT caspofungin induced, flucytosine repressed; downregulated
FT in core stress response"
FT CDS 4248..4778
FT /gene="orf19.1925"
FT /Ca19Contig="Ca19-10136|complement(14856..15386)"
FT /synonym="orf19.9481, IPF17379.3, IPF14847.1, orf6.1954,
FT orf6.5530, CA0809, TLO5b"
FT /remarks="Member of a family of telomere-proximal genes of
FT unknown function; may be spliced in vivo"
FT CDS complement(993481..994317)
FT /gene="orf19.193"
FT /Ca19Contig="Ca19-10044|17039..17875"
FT /synonym="orf19.7823, IPF27135.1, IPF14730.2, Contig4-
FT 2639_0009, orf6.2966, orf6.1142, CA1449"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT possibly spurious ORF (Annotation Working Group
FT prediction)"
FT CDS 991802..993409
FT /gene="orf19.194"
FT /Ca19Contig="Ca19-10044|complement(17947..19554)"
FT /synonym="orf19.7824, IPF19562.1, IPF19563.2, Contig4-
FT 2639_0010, orf6.1143, orf6.197, CA0334"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT possibly spurious ORF (Annotation Working Group
FT prediction)"
FT CDS join(complement(1853562..1854716),
FT complement(1852994..1853560))
FT /gene="orf19.198"
FT /Ca19Contig="Ca19-10045|1181..2902"
FT /synonym="orf19.7828, IPF27104.1, IPF9072.3, Contig4-
FT 1950_0002, Contig4-1950_0005, orf6.209, orf6.5930"
FT /remarks="Protein described as asparagine synthetase;
FT soluble protein in hyphae; regulated by Rim101p; decreased
FT expression at pH 4 compared to pH 8"
FT CDS join(complement(235450..236451),
FT complement(235092..235448))
FT /gene="orf19.1989"
FT /Ca19Contig="Ca19-10139|233..1591"
FT /synonym="orf19.9540, IPF25268.1, IPF15224.2, Contig4-
FT 2093_0006, orf6.1293, CA0403"
FT /remarks="Protein with predicted GPI modification; dfg5
FT dcw1 double mutant is inviable; not required for wild-type
FT hyphal growth; increased mRNA abundance observed in cyr1
FT homozygous null mutant (yeast-form or hyphal); fungal-
FT specific"
FT CDS complement(1850615..1852150)
FT /gene="orf19.199"
FT /Ca19Contig="Ca19-10045|3746..5281"
FT /synonym="orf19.7829, IPF27109.1, IPF9069.2, Contig4-
FT 1852_0003, Contig4-1950_0007, orf6.5931, CA3617"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT hyphal-induced expression; greater mRNA abundance observed
FT in a cyr1 homozygous null mutant than in wild type"
FT CDS complement(232605..234497)
FT /gene="orf19.1990"
FT /Ca19Contig="Ca19-10139|2186..4078"
FT /synonym="orf19.9541, IPF25265.1, IPF15225.2, Contig4-
FT 2093_0003, Contig4-2093_0004, orf6.1292, orf6.6370,
FT CA0402"
FT /remarks="Protein induced during the mating process"
FT CDS 230559..232292
FT /gene="orf19.1991"
FT /Ca19Contig="Ca19-10139|complement(4391..6250)"
FT /synonym="orf19.9542, IPF19793.1, IPF16743.2, Contig4-
FT 1687_0002, orf6.1291, orf6.6369, CA3950"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(227627..229186)
FT /gene="orf19.1992"
FT /Ca19Contig="Ca19-10139|7497..9056"
FT /synonym="orf19.9544, IPF17303.2, IPF18997.2, orf6.6367,
FT CA3949"
FT /remarks="Regulator of phenotypic switching in strain
FT 3153A; mutation does not affect white-opaque switching
FT rate in strain WO-1; similar to S. cerevisiae Sir2p;
FT partially functionally complements S. cer